<SEC-DOCUMENT>0001570562-21-000102.txt : 20210326
<SEC-HEADER>0001570562-21-000102.hdr.sgml : 20210326
<ACCEPTANCE-DATETIME>20210326083245
ACCESSION NUMBER:		0001570562-21-000102
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20210326
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210326
DATE AS OF CHANGE:		20210326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evolus, Inc.
		CENTRAL INDEX KEY:			0001570562
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				461385614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38381
		FILM NUMBER:		21774825

	BUSINESS ADDRESS:	
		STREET 1:		520 NEWPORT CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		(949) 284-4555

	MAIL ADDRESS:	
		STREET 1:		520 NEWPORT CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eols-20210326.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642,d:18795be27dea4a8bb9608ca2068e4a78--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>eols-20210326</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF80L2ZyYWc6NGZiYWEyYzc5MGRjNGEzZTg2YjdlOWJiM2Y4NGU2MTEvdGFibGU6MzYyNmVkMmNhMThmNDI0ZGJjNmVlNjIxMmU4M2U0ZTYvdGFibGVyYW5nZTozNjI2ZWQyY2ExOGY0MjRkYmM2ZWU2MjEyZTgzZTRlNl8yLTEtMS0xLTA_b30f32bf-0784-43b5-99c6-a1979a7b8e6d">0001570562</ix:nonNumeric><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF80L2ZyYWc6NGZiYWEyYzc5MGRjNGEzZTg2YjdlOWJiM2Y4NGU2MTEvdGFibGU6MzYyNmVkMmNhMThmNDI0ZGJjNmVlNjIxMmU4M2U0ZTYvdGFibGVyYW5nZTozNjI2ZWQyY2ExOGY0MjRkYmM2ZWU2MjEyZTgzZTRlNl81LTEtMS0xLTA_59195bf0-738e-42b9-a687-596f78afb2c8">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="eols-20210326.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001570562</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i18795be27dea4a8bb9608ca2068e4a78_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">&#160;UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI5_4bfc6fcf-60ab-4802-ad04-85f4812377c2">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8yMjc_97ab0a8b-86fc-4b24-a122-b035c67fae14">March 26, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMw_09b8950b-63ea-4595-85a4-5b737c401199">EVOLUS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.200%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.567%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTAtMS0xLTA_d8f3c312-365b-473c-b08e-4a575dc0234f">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTItMS0xLTA_fab0fd29-89a8-45ac-9f1c-52373294f26f">001-38381</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTQtMS0xLTA_783df5ab-3923-4161-b6ab-1659b21d7ff2">46-1385614</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIx_c9358455-c388-4990-9319-d9bb2d37679b">520 Newport Center Drive, Suite 1200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM2_eb79cc37-5a9b-4f7a-9bd7-167865dbe820">Newport Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMx_3c88c229-ae62-4c49-8d2e-c007cd07193a">California</ix:nonNumeric> <ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMy_980e88e9-e46e-4307-8e8c-e42380b68b3c">92660</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIy_d5eca46e-95b6-4d2a-b790-0c77fd0dfd4d">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM3_bcac74f4-7b75-4edb-ab8a-d86d0e9aa861">284-4555</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM5_0516c917-1b6b-408a-bc6d-3537c5957dc6">&#9744;</ix:nonNumeric>&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIw_a237d3fa-aee1-454d-bb29-7ab2616c600b">&#9744;</ix:nonNumeric>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI2_c31c91ef-bcc9-4bf3-aec8-aef4199d5577">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM1_28e041f0-6289-4387-8eb9-4025883ca04f">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.025%"><tr><td style="width:1.0%"></td><td style="width:34.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTAtMS0xLTA_7ce63da9-68b7-45bc-a138-153d4da49062">Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTEtMS0xLTA_3288e5bc-f7cb-46be-81bc-197f95fe4534">EOLS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTItMS0xLTAvdGV4dHJlZ2lvbjpiNGQ5YWIzMDU2YmU0NjIxODk2MjYyYmQwMGZlNjliZF80_470032b0-9cee-4c20-9306-9896460a97f6">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Nasdaq Global Market)</span></div><div style="text-align:center"><span><br/></span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI4_e556b972-e999-49ce-ab12-b3fc6ee4ead8">&#9745;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM0_866a3af5-6e7b-41d5-a230-836bdeb34cc9">&#9745;</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div><div id="i18795be27dea4a8bb9608ca2068e4a78_7"></div><hr style="page-break-after:always"/><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 26, 2021, Evolus, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into an open market sales agreement (the &#8220;Sales Agreement&#8221;) with SVB Leerink LLC, as sales agent (the &#8220;Sales Agent&#8221;), in connection with the offer and sale from time to time by the Company of shares of the Company&#8217;s common stock, par value $0.00001 per share, having an aggregate offering price of up to $75,000,000 (&#8220;ATM Shares&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any ATM Shares to be offered and sold under the Sales Agreement will be issued and sold pursuant to the Company&#8217;s previously filed and currently effective registration statement on Form S-3 (File No. 333-230466).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A prospectus supplement relating to the offering of ATM Shares was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March&#160;26, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subject to the terms and conditions of the Sales Agreement, the Sales Agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of The Nasdaq Stock Market, LLC (&#8220;Nasdaq&#8221;), to sell ATM Shares from time to time based upon the Company&#8217;s instructions, including any price, time or size limits or other customary parameters or conditions the Company may impose.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the Sales Agreement, the Sales Agent may sell ATM Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the rules and regulations thereunder, including, without limitation, sales made directly on or through Nasdaq, on or through any other existing trading market for the Company&#8217;s shares of common stock or to or through a market maker. If expressly authorized by the Company, the Sales Agent may also sell ATM Shares in privately negotiated transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company agreed to pay the Sales Agent a commission equal to 3.0% of the gross proceeds from the sales of ATM Shares pursuant to the Sales Agreement. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company made certain customary representations, warranties and covenants in the Sales Agreement. The Sales Agreement also contains customary indemnification obligations of the Company and the Sales Agent, including for liabilities under the Securities Act, and termination provisions.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provisions of the Sales Agreement, including the representations and warranties contained therein, are not for the benefit of any party other than the parties to such agreements and are not intended as documents for investors and the public to obtain factual information about the current state of affairs of the parties to those documents and agreements. Rather, investors and the public should look to other disclosures contained in the Company&#8217;s filings with the SEC.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company plans to use the net proceeds from this offering to fund the commercialization of Jeuveau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and for working capital and other general corporate purposes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s management will have broad discretion over the actual amounts and timing of the expenditure of the net proceeds from the offering of ATM Shares. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The foregoing summary of the terms of the Sales Agreement is subject to, and qualified in its entirety by reference to, the Sales Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K, and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i18795be27dea4a8bb9608ca2068e4a78_13"></div><hr style="page-break-after:always"/><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="padding-left:63pt;text-indent:-63pt"><span><br/></span></div><div style="padding-left:90pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:9.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex11032621.htm">Sales Agreement, dated March 26, 2021, by and between Evolus, Inc. and SVB Leerink LLC as Sales Agent.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex5132621.htm">Opinion of O&#8217;Melveny &amp; Myers LLP.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex5132621.htm">Consent of O&#8217;Melveny &amp; Myers LLP (included in Opinion of O&#8217;Melveny &amp; Myers LLP filed as Exhibit 5.1).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i18795be27dea4a8bb9608ca2068e4a78_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:2pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:59.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Evolus, Inc.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: March 26, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Moatazedi</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Moatazedi</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex11032621.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i96a9a857120a46ab9ef2c67d5069d10d_1"></div><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">EVOLUS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Shares of Common Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">($0.00001 par value per share)</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SALES AGREEMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">March 26, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SVB LEERINK LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1301 Avenue of the Americas, 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Floor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">New York, New York  10019</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Evolus, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), confirms its agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) with SVB Leerink LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), as follows&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:27.75pt;text-decoration:underline">Issuance and Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through the Agent up to $75.0 million of shares of common stock, $0.00001 par value per share, of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), subject to the limitations set forth in Section 5(c) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this Section 1 on the aggregate gross sales price of Placement Shares that may be issued and sold under this Agreement from time to time shall be the sole responsibility of the Company, and that the Agent shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through the Agent will be effected pursuant to the Registration Statement (as defined below) filed by the Company with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and initially declared effective by the Commission April 15, 2019, although nothing in this Agreement shall be construed as requiring the Company to issue any Placement Shares.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company has prepared and filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), with the Commission a registration statement on Form S-3 (File No. 333-230466), including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). The Company has prepared a prospectus supplement to the base prospectus included as part of such registration statement at the time the registration statement became effective, which prospectus supplement specifically relates to the Placement Shares to be issued from time to time pursuant to this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). The Company will furnish to the Agent, for use by the Agent, copies of the base prospectus included as part of such registration statement at the time it became effective, as supplemented by the Prospectus Supplement. Except where the context otherwise requires, such registration statement, as amended at the time of its effectiveness for purposes of Section 11 of the Securities Act, as such section applies to the Agent, including all documents incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or Rule 462(b) under the Securities Act at such effective time, is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.&#8221; The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and&#47;or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#8220;issuer free writing prospectus&#8221; (as used herein, as defined in Rule 433 under the Securities Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Rule 433</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)), relating to the Placement Shares that (i) is required to be filed with the Commission by the Company or (ii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case, in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g), is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.&#8221;</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Any reference herein to the Registration Statement, the Prospectus Supplement, the Prospectus or any issuer free writing prospectus shall be deemed to refer to and include the documents, if any, that are or are deemed to be incorporated by reference therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Incorporated Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). Any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, the Prospectus Supplement, the Prospectus or any issuer free writing prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act on or after the most-recent effective date of the Registration Statement, or the respective dates of the Prospectus Supplement, Prospectus or such issuer free writing prospectus, as the case may be, and incorporated therein by reference. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System or, if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">EDGAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:27.75pt;text-decoration:underline">Placements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Each time that the Company wishes to issue and sell any Placement Shares through the Agent hereunder (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), it will notify the Agent by email notice (or other method mutually agreed to in writing by the parties) (each such notice, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Placement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) containing the parameters in accordance with which it desires such Placement Shares to be sold, which at a minimum shall include the maximum number or amount of Placement Shares to be sold, the time period during which sales are requested to be made, any limitation on the number or amount of Placement Shares that may be sold in any one Trading Day (as defined in Section 3) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Placement Notice must originate from one of the individuals authorized to act on behalf of the Company and set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> (with a copy to each of the other individuals from the Company listed on such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), and shall be addressed to each of the recipients from the Agent set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, as such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> may be updated by either party from time to time by sending a written notice containing a revised </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> to the other party in the manner provided in Section 12 (including by email correspondence to each of the individuals of the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply). The Placement Notice shall be effective upon confirmation of receipt by the Agent (including by email or telephone) to the individual(s) of the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> who submitted the Placement Notice, unless and until (i) in accordance with the notice requirements set forth in Section 4, the Agent declines to accept the terms contained therein for any reason, in its sole discretion, within one Trading Day of the date the Agent receives the Placement Notice, (ii) the entire amount of the Placement Shares has been sold pursuant to this Agreement, (iii) in accordance with the notice requirements set forth in Section 4, the Company suspends sales under or terminates the Placement Notice for any reason in its sole discretion, (iv) the Company issues a subsequent Placement Notice and explicitly indicates that its parameters supersede those contained in the earlier dated Placement Notice or (v) this Agreement has been terminated pursuant to the provisions of Section 11. The amount of any discount, commission or other compensation to be paid by the Company to the Agent in connection with the sale of the Placement Shares effected through the Agent shall be calculated in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Agent and such Placement Notice has been confirmed by the Agent pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control with respect to the matters covered thereby.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:27.75pt;text-decoration:underline">Sale of Placement Shares by the Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, including Section 5(c), upon the Agent&#8217;s confirmation of the terms of a Placement Notice as provided in Section 2, and unless the sale of the Placement Shares described therein has been declined, suspended or otherwise terminated in accordance with the terms of this Agreement, the Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations  and the rules of the Nasdaq to sell such Placement Shares up to the number or amount specified in, and otherwise in accordance with the terms of, such Placement Notice.  The Agent will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) following the close of trading on Nasdaq (as defined in Section 6(q)) on </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the Trading Day (as defined below) on which it has made sales of Placement Shares hereunder setting forth the number or amount of Placement Shares sold on such Trading Day, the volume-weighted average price of the Placement Shares sold, the commission payable to the Agent with respect to such Placement Shares sold and the Net Proceeds (as defined below) payable to the Company.  Unless otherwise specified by the Company in a Placement Notice, the Agent may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act (which may include block transactions), including sales made directly on or through Nasdaq, on or through any other existing trading market for the Common Stock or to or through a market maker. If expressly authorized by the Company (including in a Placement Notice), the Agent may also sell Placement Shares in privately negotiated transactions. Notwithstanding the provisions of Section 6(tt), except as may be otherwise agreed by the Company and the Agent, the Agent shall not purchase Placement Shares on a principal basis pursuant to this Agreement unless the Company and the Agent enter into a separate written agreement setting forth the terms of such sale. The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Placement Shares, (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of Nasdaq to sell such Placement Shares as required under this Agreement and (iii) the Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement unless the Company and the Agent enter into a separate written agreement setting forth the terms of such sale. For the purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means any day on which the Common Stock is purchased and sold on Nasdaq.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:27.75pt;text-decoration:underline">Suspension of Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;The Company or the Agent may, upon notice sent by one of the individuals named on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> hereto to the to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), suspend any sale of Placement Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that such suspension shall not affect or impair either party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice (including with respect to Placement Shares sold that have not yet settled).  Each of the parties agrees that no such notice under this Section 4 shall be effective against the other party unless notice is sent by one of the individuals named on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> hereto to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and the Agent agree that (i) no sale of Placement Shares will take place (other than Placement Shares sold while the Company was not in possession of material non-public information that have not yet settled), (ii) the Company shall not request the sale of any Placement Shares and shall cancel any effective Placement Notices instructing the Agent to make any sales and (iii) the Agent shall not be obligated to sell or offer to sell any Placement Shares. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:27.75pt;text-decoration:underline">Settlement and Delivery of the Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Settlement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second Trading Day (or such earlier day as is industry practice or as is required for regular-way trading) following the date on which such sales are made (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Settlement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).  The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Net Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) will be equal to the aggregate gross sales price received by the Agent at which such Placement Shares were sold, after deduction of (i) the Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof, and (ii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Delivery of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On or before each Settlement Date, the Company will issue the Placement Shares being sold on such date and will, or will cause its transfer agent to, </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">electronically transfer such Placement Shares by crediting the Agent&#8217;s or its designee&#8217;s account (provided the Agent shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">DWAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) or by such other means of delivery as may be mutually agreed upon by the parties hereto, which in all cases shall be duly authorized, freely tradeable, transferable, registered shares of Common Stock in good deliverable form. On each Settlement Date, the Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on or prior to the Settlement Date. The Agent shall be responsible for providing DWAC instructions or other instructions for delivery by other means with regard to the transfer of the Placement Shares being sold. In addition to and in no way limiting the rights and obligations set forth in Section 9(a) hereto, the Company agrees that if the Company or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized, freely tradeable, transferable, registered Placement Shares in good deliverable form by 2&#58;30 P.M., New York City time, or such other time as mutually agreed upon, on a Settlement Date (other than as a result of a failure by the Agent to provide instructions for delivery), the Company will (i) take all necessary action to cause the full amount of any Net Proceeds that were delivered to the Company&#8217;s account with respect to such settlement, together with any costs incurred by the Agent and&#47;or its clearing firm in connection with recovering such Net Proceeds, to be immediately returned to the Agent or its clearing firm no later than 5&#58;00 P.M., New York City time, or such other time as mutually agreed upon, on such Settlement Date, by wire transfer of immediately available funds to an account designated by the Agent or its clearing firm, (ii) indemnify and hold the Agent harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii) pay to the Agent any commission, discount or other compensation to which it would otherwise have been entitled absent such default. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Limitations on Offering Size</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate number or gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser of&#58; (i) the number or dollar amount of shares of Common Stock registered pursuant to, and available for offer and sale under, the Registration Statement pursuant to which the offering of Placement Shares is being made, (ii) the number of authorized but unissued shares of Common Stock of the Company (less shares of Common Stock issuable upon exercise, conversion or exchange of any outstanding securities of the Company or otherwise reserved from the Company&#8217;s authorized capital stock), (iii) the number or dollar amount of shares of Common Stock permitted to be offered and sold by the Company under Form S-3 (including General Instruction I.B.6. thereof, if such instruction is applicable), (iv) the number or dollar amount of shares of Common Stock that the Company&#8217;s board of directors or a duly authorized committee thereof is authorized to issue and sell from time to time pursuant to this Agreement, and notified to the Agent in writing, or (v) the dollar amount of shares of Common Stock for which the Company has filed the Prospectus Supplement.  Under no circumstances shall the Company cause or request, or the Agent effect, the offer or sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Company&#8217;s board of directors or a duly authorized committee thereof, and notified to the Agent in writing. Notwithstanding anything to the contrary contained herein, the parties hereto acknowledge and agree that compliance with the limitations set forth in this Section 5(c) on the number or dollar amount of Placement Shares that may be issued and sold under this Agreement from time to time (but not any minimum price authorized with respect to the offer or sale of any Placement Shares of which the Agent has been notified in writing) shall be the sole responsibility of the Company, and that the Agent shall have no obligation in connection with such compliance.  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company represents and warrants to, and agrees with, the Agent that as of the date of this Agreement, and as of (i) each Representation Date (as defined in Section 7(m)), (ii) each date on which a Placement Notice is given, (iii) the date and time of each sale of any Placement Shares pursuant to this Agreement (each, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Time of Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and (iv) each Settlement Date (each such time or date referred to in clauses (i) through (iv), an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Applicable Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;The Company and the transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form S-3 (including General Instructions I.A and I.B.1.) under the Securities Act. The Registration Statement has been filed with the Commission and has been declared effective by the Commission under the Securities Act prior to the issuance of any Placement Notices by the Company. At the time the Registration Statement originally became effective and at the time the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, was filed with the Commission, the Company met the then-applicable requirements for use of Form S-3 </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(including General Instructions I.A and I.B.1.) under the Securities Act. The Registration Statement meets, and the offering and sale of Placement Shares as contemplated hereby comply with, the requirements of Rule 415(a)(1)(x) under the Securities Act. The Agent is named as the agent engaged by the Company in the section entitled &#8220;Plan of Distribution&#8221; in the Prospectus Supplement. The Company has not received, and has no notice from the Commission of, any notice pursuant to Rule 401(g)(1) under the Securities Act objecting to the use of the shelf registration statement form. No stop order of the Commission preventing or suspending the use of the base prospectus, the Prospectus Supplement or the Prospectus, or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose are pending before or, to the knowledge of the Company, threatened by the Commission. At the time of the initial filing of the Registration Statement, the Company paid the required Commission filing fees relating to the securities covered by the Registration Statement, including the Shares that may be sold pursuant to this Agreement, in accordance with Rule 457(o) under the Securities Act.  Copies of the Registration Statement, the Prospectus, any such amendments or supplements to any of the foregoing and all Incorporated Documents that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Agent and its counsel.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;Each of the Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective, at each deemed effective date with respect to the Agent pursuant to Rule 430B(f)(2) under the Securities Act and as of each Time of Sale and Settlement Date, complied, complies and will comply in all material respects with the requirements of the Securities Act and did not, does not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, except that the representations and warranties set forth in this sentence do not apply to Agent&#8217;s Information (as defined below). The Prospectus, as amended or supplemented, when so filed with the Commission under Rule 424(b) under the Securities Act, complied and as of each Time of Sale and Settlement Date will comply in all material respects with the requirements of the Securities Act, and each Prospectus Supplement, Prospectus or issuer free writing prospectus (or any amendments or supplements to any of the foregoing) furnished to the Agent for use in connection with the offering of the Placement Shares was identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T. The Prospectus, as amended or supplemented, as of its date and as of the Time of Sale and the Settlement Date, did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this sentence do not apply to Agent&#8217;s Information. Each Incorporated Document heretofore filed, when it was filed (or, if any amendment with respect to any such document was filed, when such amendment was filed), conformed in all material respects with the requirements of the Exchange Actand did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;(i) At the time of filing the Registration Statement and (ii) at the time of the execution of this Agreement (with such date being used as the determination date for purposes of this clause (ii)), the Company was not and is not an &#8220;ineligible issuer&#8221; (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Each issuer free writing prospectus, as of its issue date and as of each Applicable Time, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any Incorporated Document deemed to be a part thereof that has not been superseded or modified. Each issuer free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433 or that was prepared by or on behalf of or used by the Company complies or will comply in all material respects with the requirements of the Securities Act. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;The Company has not distributed any offering material in connection with the offering and sale of the Placement Shares other than the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus (as defined below). </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus, the Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Emerging Growth Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(g)&#160;&#160;&#160;&#160;The Company has the requisite corporate power and authority to enter into this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(h)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus or waived, there are no persons with registration or other similar rights to have any equity or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this Agreement nor, to have any equity or debt securities, or any rights exercisable for or convertible or exchangeable into such securities, registered for sale on any other registration statement to be filed by the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus&#58; (i) there has been no change or any development that could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect (as hereinafter defined), (ii) the Company and its subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect, direct or contingent, including without limitation any losses or interference with its business from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material, individually or in the aggregate, to the Company and its subsidiaries, considered as one entity, or has entered into any transactions not in the ordinary course of business, and (iii) there has not been any material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or by any of the Company&#8217;s subsidiaries on any class of capital stock, or any repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(j)&#160;&#160;&#160;&#160;Ernst &#38; Young LLP, which has expressed its opinion with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) filed with the Commission and incorporated by reference as a part of the Registration Statement and the Prospectus, is an independent registered public accounting firm as required by the Securities Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">PCAOB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(k)&#160;&#160;&#160;&#160;The consolidated financial statements filed with the Commission and incorporated by reference as a part of the Registration Statement and the Prospectus, present fairly in all material respects the consolidated financial position of the Company as of the dates indicated and the results of their operations, changes in stockholders&#8217; equity and cash flows for the periods specified. Such financial statements have been prepared in conformity with generally accepted accounting principles as applied in the United States applied on a consistent basis throughout the periods involved (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), except as may be expressly stated in the related notes thereto. The interactive data in eXtensible Business Reporting Language included in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. No other financial statements or supporting schedules are required to be included in the Registration Statement or the Prospectus. All disclosures contained in the Registration Statement or the Prospectus and any free writing prospectus, that constitute non-GAAP financial measures (as defined by the rules and regulations under the Securities Act and the Exchange Act) comply with Regulation G under the Exchange Act and Item 10 of Regulation S-K under the Securities Act, as applicable. To the Company&#8217;s knowledge, no person who has been suspended or barred from being associated with a registered public accounting firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise aided the preparation of, or audited, the financial statements or other financial data filed with the Commission as a part of the Registration Statement and the Prospectus.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(l)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries make and keep books and records that are accurate in all material respects and maintain a system of internal accounting controls sufficient to provide reasonable assurance that&#58; (i) transactions are executed in accordance with management&#8217;s general or specific authorization, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(m)&#160;&#160;&#160;&#160;The Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act) that comply with the requirements of the Exchange Act, which (i) are designed to ensure that material information relating to the Company, including its consolidated subsidiaries, if any, are made known to the Company&#8217;s principal executive officer and its principal financial officer by others within those entities, and (ii) are effective in all material respects to perform the functions for which they were established, in each case, except as disclosed in the Registration Statement and the Prospectus. Except as disclosed in the Registration Statement and the Prospectus, since the end of the Company&#8217;s most recent audited fiscal year, there have been no significant deficiencies or material weaknesses in the Company&#8217;s internal control over financial reporting (whether or not remediated) and there has been no change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. Except as disclosed in the Registration Statement and the Prospectus, the Company is not aware of any change in its internal control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(n)&#160;&#160;&#160;&#160;The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus and to enter into and perform its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good standing in the State of California and each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing would not reasonably be expected, individually or in the aggregate, to have a material adverse effect on the condition (financial or other), business, properties, operations, assets, liabilities or prospects of the Company and its subsidiaries, considered as one entity, or would materially and adversely affect the ability of the Company to perform its obligations under this Agreement and to consummate the transactions contemplated by this Agreement and the Prospectus (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(o)&#160;&#160;&#160;&#160;Each of the Company&#8217;s &#8220;subsidiaries&#8221; (for purposes of this Agreement, as defined in Rule 405 under the Securities Act) has been duly incorporated or organized, as the case may be, and is validly existing as a corporation, partnership or limited liability company, as applicable, in good standing under the laws of the jurisdiction of its incorporation or organization and has the power and authority (corporate or other) to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, except where the failure to be in good standing or have such power and authority would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Each of the Company&#8217;s subsidiaries is duly qualified as a foreign corporation, partnership or limited liability company, as applicable, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. All of the issued and outstanding capital stock or other equity or ownership interests of each of the Company&#8217;s subsidiaries have been duly authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim, except as otherwise would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(p)&#160;&#160;&#160;&#160;The Common Stock conforms in all material respects to the description thereof contained in the Registration Statement and the Prospectus. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and nonassessable and have been issued in compliance with all applicable federal and state securities laws. None of the outstanding shares of Common Stock was issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(q)&#160;&#160;&#160;&#160;The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The Nasdaq Global Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Nasdaq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the Company&#8217;s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(r)&#160;&#160;&#160;&#160;Neither the Company nor any of its subsidiaries is in violation of its charter or by laws, partnership agreement or operating agreement or similar organizational documents, as applicable, or is in default (or, with the giving of notice or lapse of time, would be in default) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) under any indenture, loan, credit agreement, note, lease, license agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or to which any of their respective properties or assets are subject (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Existing Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), except for such violations or Defaults as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. The Company&#8217;s execution, delivery and performance of this Agreement, consummation of the transactions contemplated hereby and by the Registration Statement and the Prospectus (i) have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the charter or by laws, partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company or any subsidiary, (ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument, which consent has not been obtained by the Company, and (iii) will not result in any violation of any Law applicable to the Company or any of its subsidiaries (including, without limitation, those promulgated by the United States Food and Drug Administration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) or by any Governmental Authority (as defined herein) performing functions similar to those performed by the FDA), except in the case of clauses (ii) and (iii) for such conflicts, breaches, Defaults, liens, charges, encumbrances or violations that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No consent, approval, authorization or other order of, or registration or filing with, any Governmental Authority is required for the Company&#8217;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby and by the Registration Statement and the Prospectus, except such as have been obtained or made by the Company and are in full force and effect under the Securities Act and such as may be required under Securities Act, the rules of the Nasdaq, applicable state securities or blue sky laws or the Financial Industry Regulatory Authority (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">FINRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). As used herein, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Debt Repayment Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(s)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus, the Company and each of its subsidiaries (i) has been at all times and is in compliance with all applicable laws, including, without limitation, all laws applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company or its subsidiaries (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Healthcare Product Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), except where failure to be so in compliance would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any other Governmental Authority alleging or asserting noncompliance with any Healthcare Product Laws or any licenses, certificates, approvals, clearances, authorizations, orders, permits, supplements or amendments required by any Healthcare Product Law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), (iii) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Authority or third party alleging that any product, operation or activity is in violation of any Healthcare Product Law or Permit, and has no knowledge that any Governmental Authority or third party has threatened any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action, (iv) has filed, obtained, maintained and submitted all material filings, listings, registrations, reports, declarations, forms, notices, applications, records, claims, submissions, supplements, amendments or other documents as required by any Healthcare Product Law or Permit, and all such filings, listings, registrations, reports, declarations, forms, notices, applications, records, claims, submissions, supplements, amendments or other documents were complete and correct on the date filed in all material respects, (v) have at all times complied in all material respects with all applicable laws, rules and regulations relating to privacy, data protection, and the collection and use of personal information, and (vi) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post-sale warning, &#8220;dear doctor&#8221; letter, or other notice or action </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation and, to the Company&#8217;s and each subsidiary&#8217;s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(t)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus, (i) there is no action, suit, proceeding, inquiry or investigation brought by or before any Governmental Authority now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect&#59; and (ii) the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary is a party or of which any of their respective properties or assets is the subject, including ordinary routine litigation incidental to the business, if any such matters are determined adversely to the Company or the other defendants thereof, would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No material labor dispute with the employees of the Company or any of its subsidiaries, or, to the Company&#8217;s knowledge, with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(u)&#160;&#160;&#160;&#160;The Company and its subsidiaries own, or have obtained and maintain valid and enforceable licenses for, the inventions, patent applications, patents, trademarks, service marks, trade names, service names, domain names, copyrights, technology, know-how, trade secrets and other intellectual property described in the Registration Statement and the Prospectus as being owned or licensed by them or which are necessary for the conduct of their respective businesses as currently conducted or as currently proposed to be conducted as described in the Registration Statement and the Prospectus (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and, except as otherwise disclosed in the Registration Statement, and the Prospectus, the Company is unaware of any claim to the contrary or any challenge by any other person to the rights of the Company or any of its subsidiaries with respect to the Intellectual Property. To the Company&#8217;s knowledge, and except as otherwise disclosed in the Registration Statement and the Prospectus or as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect&#58; (i) there are no third parties who have rights to any Intellectual Property, except for customary reversionary rights of third-party licensors with respect to Intellectual Property that is disclosed in the Registration Statement and the Prospectus as licensed to the Company or one or more of its subsidiaries, and (ii) there is no infringement, misappropriation or other violation by third parties of any Intellectual Property. Except as otherwise disclosed in the Registration Statement and the Prospectus or as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, litigation, arbitration, proceeding or claim by others&#58; (A) challenging the Company&#8217;s or any of its subsidiaries&#8217; rights in or to (or use of) any Intellectual Property and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, litigation, arbitration, proceeding or claim&#59; (B) challenging the validity, enforceability or scope of any Intellectual Property and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, litigation, arbitration, proceeding or claim&#59; or (C) asserting that the Company or any of its subsidiaries infringes, misappropriates or otherwise violates, or would, upon the commercialization of any product or service described in the Registration Statement or the Prospectus, infringe, misappropriate or otherwise violate, any patent, trademark, service mark, trade name, service name, copyright, know-how, trade secret or other intellectual property or proprietary rights of others and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, litigation, arbitration, proceeding or claim. The Company and its subsidiaries (and, to the Company&#8217;s knowledge, the other parties thereto) have complied (and are in compliance) in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or any subsidiary, no counterparty thereto has asserted the existence of any default thereunder by the Company or any of its subsidiaries, and all such agreements are in full force and effect and are valid, binding upon, and enforceable by or against the Company or such subsidiary (and, to the Company&#8217;s knowledge, the other parties thereto), as applicable, in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency or similar laws affecting the rights of creditors generally and general equitable principles. None of the technology or other intellectual property employed by the Company or any of its subsidiaries has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company or any of its subsidiaries or, to the Company&#8217;s knowledge, upon any officers, directors or employees of the Company or any of its subsidiaries, and to the Company&#8217;s knowledge, none of its or its subsidiaries&#8217; employees are in or have ever been in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#8217;s </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">breach of a confidentiality obligation, obligation to assign intellectual property to an employer, or obligation not to use third-party intellectual property or other proprietary rights of a third party, except for any such violations as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. The product described in the Registration Statement and the Prospectus falls within the scope of the Intellectual Property owned by, or exclusively licensed in certain jurisdictions as described in the Registration Statement and the Prospectus to, the Company or any subsidiary. The Company and its subsidiaries have taken reasonable steps to protect and maintain the confidentiality of their trade secrets and other confidential Intellectual Property.  The Company is not a party to or bound by any options, licenses or agreements with respect to the Intellectual Property of any other person or entity that are required to be set forth in the Registration Statement or the Prospectus and are not described therein.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(v)&#160;&#160;&#160;&#160;The Company and its subsidiaries own or have a valid right to access and use all material computer systems, networks, hardware, software, databases, websites, and equipment used to process, store, maintain and operate data, information, and functions used in connection with the business of the Company and its subsidiaries (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Company IT Systems</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). The Company IT Systems (i) are adequate for, and operate and perform in all material respects as required in connection with, the operation of the business of the Company and its subsidiaries as currently conducted, and (ii) are free of any viruses, &#8220;back doors,&#8221; &#8220;Trojan horses,&#8221; &#8220;time bombs,&#8221; &#8220;worms,&#8221; &#8220;drop dead devices&#8221; or other software or hardware components that are designed to interrupt use of, permit unauthorized access to, or disable, damage or erase, any software material to the business of the Company or any of its subsidiaries, except in the case of (i) and (ii) as would not be reasonably be expected to result in a Material Adverse Effect. The Company and its subsidiaries have implemented commercially reasonable backup, security and disaster recovery technology consistent in all material respects with applicable regulatory standards and customary industry practices. To the knowledge of the Company, no third party has breached or compromised the integrity or security of the Company IT Systems in a manner which would reasonably be expected to result in a Material Adverse Effect. The Company and its subsidiaries have at all times complied in all material respects with all applicable laws relating to privacy, data protection, and the collection and use of personal information collected, used, or held for use by the Company or any of its subsidiaries in the conduct of its business. No claims have been asserted or, to the Company&#8217;s knowledge, threatened against the Company or any subsidiary alleging a violation of any person&#8217;s privacy or personal information or data rights, and the consummation of the transactions contemplated hereby will not breach or otherwise cause any violation of any Law related to privacy, data protection, or the collection and use of personal information collected, used, or held for use by the Company or any of its subsidiaries in the conduct of its business, except as otherwise disclosed in the Registration Statement and the Prospectus. The Company and its subsidiaries take reasonable measures to ensure that such information is protected against unauthorized access, use, modification, or other misuse.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(w)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries possesses, or qualify for applicable exemptions to, all material Permits required by any Healthcare Product Law or Governmental Authority to conduct their respective businesses as currently conducted and as described in the Registration Statement or the Prospectus, including, without limitation, any Investigational New Drug Application (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">IND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), New Drug Application (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">NDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), or Biologics License Application (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">BLA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) as required by the FDA or other Permits issued by any Regulatory Agency (as defined below). For the purposes of this agreement, &#8220;Regulatory Agency&#8221; shall mean any Governmental Authority, including, without limitation, the FDA, the European Medicines Agency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">EMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and Health Canada, any institutional review board, or other regulatory body engaged in or responsible for the regulation or oversight of pharmaceuticals and biological products such as those being licensed, developed, tested, marketed and sold by the Company and its subsidiaries. Each such Permit is valid and in full force and effect. Except as otherwise disclosed in the Registration Statement and the Prospectus, neither the Company nor its subsidiaries have failed to file with any applicable Regulatory Agency or other Governmental Authority any required filings, listings, registrations, reports, declarations, forms, notices, applications, records, claims, submissions, supplements, amendments or other documents&#59; each such filing, listing, registration, report, declaration, form, notice, application, record, claim, submission, supplement, amendment or other document was complete, correct and compliant in all material respects with all Healthcare Product Laws when filed&#59; and no material deficiencies have been asserted by any Regulatory Agency or other Governmental Authority with respect to any such filings or submissions. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, neither the Company nor any of its subsidiaries is in violation of, or in default under, any of the Permits, and neither the Company nor any of its subsidiaries has received any notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration, action or other proceedings or threatened proceedings alleging or relating to the revocation, </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">termination, modification, limitation, suspension or impairment of rights of, or non-compliance with, any such Permit, and has no knowledge that any Governmental Authority or other third party is considering any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration, action or other proceedings.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(x)&#160;&#160;&#160;&#160;The Company and its subsidiaries have good and marketable title to all of the real and personal property and other assets reflected as owned in the financial statements referred to in Section 6(k) above, in each case free and clear of any security interests, mortgages, liens, encumbrances, equities, adverse claims and other defects, other than as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. The real property, improvements, equipment and personal property held under lease by the Company or any of its subsidiaries are held under valid and enforceable leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal property by the Company or such subsidiary.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(y)&#160;&#160;&#160;&#160;The Company and its subsidiaries have filed all necessary federal, state and foreign income and franchise tax returns or have properly requested extensions thereof and have paid all taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith and by appropriate proceedings, in each case except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement and the Prospectus, the Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section 6(k) above in respect of all federal, state and foreign income and franchise taxes for all periods as to which the tax liability of the Company or any of its subsidiaries has not been finally determined.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(z)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus, each of the Company and its subsidiaries are insured by recognized and reputable institutions with policies in such amounts and with such deductibles and covering such risks as the Company reasonably deems adequate and customary for their businesses including, but not limited to, policies covering real and personal property owned or leased by the Company and its subsidiaries against theft, damage, destruction, acts of vandalism and earthquakes and policies covering the Company and its subsidiaries for product liability claims and clinical trial liability claims. The Company has no reason to believe that it or any of its subsidiaries will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement and the Prospectus, neither the Company nor any of its subsidiaries has been denied any material insurance coverage which it has sought or for which it has applied.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(aa)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus or as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect&#58; (i) neither the Company nor any of its subsidiaries is in violation of any Law, including any Law relating to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, Laws relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), (ii) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance in all material respects with their requirements, (iii) there are no pending or, to the Company&#8217;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries, and (iv) to the knowledge of the Company, there are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or Governmental Authority, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(bb)&#160;&#160;&#160;&#160;The Company and its subsidiaries and any &#8220;employee benefit plan&#8221; (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">interpretations thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)) established or maintained by the Company, its subsidiaries or their &#8220;ERISA Affiliates&#8221; (as defined below) are in compliance in all material respects with ERISA. &#8220;ERISA Affiliate&#8221; means, with respect to the Company or any of its subsidiaries, any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) of which the Company or such subsidiary is a member. Except as disclosed in the Registration Statement and the Prospectus, none of the following exists&#58; (i) no &#8220;reportable event&#8221; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates&#59; (ii) no &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated, would have any &#8220;amount of unfunded benefit liabilities&#8221; (as defined under ERISA)&#59; (iii) neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (x) Title IV of ERISA with respect to termination of, or withdrawal from, any &#8220;employee benefit plan&#8221; or (y) Sections 412, 4971, 4975 or 4980B of the Code&#59; and (iv) each employee benefit plan established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(cc)&#160;&#160;&#160;&#160;The Company is not required to register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(dd)&#160;&#160;&#160;&#160;Neither the Company nor any of its subsidiaries has taken, directly or indirectly, any action designed to or that might cause or result in stabilization or manipulation of the price of the Placement Shares or of any &#8220;reference security&#8221; (as defined in Rule 100 of Regulation M under the Exchange Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Regulation M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)) with respect to the Placement Shares, whether to facilitate the sale or resale of the Placement Shares or otherwise, and has taken no action which would directly or indirectly violate Regulation M.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ee)&#160;&#160;&#160;&#160;There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with the applicable provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ff)&#160;&#160;&#160;&#160;There are no business relationships or related-party transactions involving the Company or any of its subsidiaries or any other person required to be described in the Registration Statement or the Prospectus that have not been described as required.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(gg)&#160;&#160;&#160;&#160;All of the information provided to the Agent or to counsel for the Agent by the Company, its counsel, its officers and directors and, to the Company&#8217;s knowledge, by the holders of any securities (debt or equity) or options to acquire any securities of the Company in connection with the offering of the Placement Shares is true, complete, correct and compliant in all material respects with FINRA&#8217;s rules and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules is true, complete and correct in all material respects.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(hh)&#160;&#160;&#160;&#160;All statistical, demographic and market-related data included in the Registration Statement or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate. To the extent required, the Company has obtained the written consent to the use of such data from such sources.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries has, in the course of its actions for, or on behalf of, the Company or any of its subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity, (ii) made any direct or indirect unlawful payment to any domestic government official, &#8220;foreign official&#8221; (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">FCPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)) or employee from corporate funds, (iii) violated or is in violation of any provision of the FCPA, or any applicable Law implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">any applicable non-U.S. anti-bribery Law, or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful or improper bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful payment or benefit, to any domestic government official, such foreign official or employee&#59; and the Company and its subsidiaries and, to the knowledge of the Company, the Company&#8217;s affiliates have conducted their respective businesses in compliance with the FCPA and any other applicable non-U.S. anti-bribery Law and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(jj)&#160;&#160;&#160;&#160;The operations of the Company and its subsidiaries are, and have been conducted at all times, in compliance with applicable financial recordkeeping and reporting requirements, including, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering Laws of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and no action, suit or proceeding by or before any Governmental Authority involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(kk)&#160;&#160;&#160;&#160;Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or person acting on behalf of the Company or any of its subsidiaries is currently subject to or the target of any economic or financial sanctions administered by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) or the U.S. Department of Statement and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">UNSC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), the European Union, or Her Majesty&#8217;s Treasury (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">HMT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), or other relevant Governmental Authority (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Sudan, Syria and the Crimea region of Ukraine (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)&#59; and the Company will not, directly or indirectly, use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, in violation of applicable Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country in violation of applicable Sanctions or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of applicable Sanctions. For the past five years, the Company and its subsidiaries have not engaged in, are not now engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country in violation of applicable Sanctions.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ll)&#160;&#160;&#160;&#160;Other than the Agent, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder&#8217;s fee or other fee or commission as a result of any transactions contemplated by this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(mm)&#160;&#160;&#160;&#160;Each financial or operational projection or other &#8220;forward-looking statement&#8221; (as defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement or the Prospectus (i) was so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those in such forward-looking statement. No such statement was made with the knowledge of an executive officer or director of the Company that it was false or misleading.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(nn)&#160;&#160;&#160;&#160;The research, preclinical tests and clinical trials, and other studies (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">studies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) conducted by, on behalf of, sponsored by or being relied upon by the Company or any of its subsidiaries, including those described in, or the results of which are referred to in, the Registration Statement or the Prospectus, were conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies, all Permits, all Healthcare Product Laws, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312 and 812, all applicable professional and scientific standards, and all applicable requirements of the FDA, the EMA and other Regulatory Agencies, including any applicable institutional review board. Each description of such studies and the </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">results therefrom in the Registration Statement or the Prospectus is accurate and complete in all material respects and fairly presents in all material respects the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(oo)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries is, and at all times has been, in compliance in all material respects with all applicable Health Care Laws, and has not engaged in activities which are, as applicable, cause for false claims liability, civil penalties, or mandatory or permissive exclusion from Medicare, Medicaid, or any other state health care program or federal health care program. For purposes of this Agreement, &#8220;Health Care Laws&#8221; means&#58; (i) the Federal Food, Drug, and Cosmetic Act, (ii) all applicable federal, state, local and foreign health care related fraud and abuse Laws, including, without limitation, the U.S. Anti-Kickback Statute (42 U.S.C. Section 1320a-7b(b)), the U.S. Physician Payment Sunshine Act (42 U.S.C. Section 1320a-7h), the U.S. Civil False Claims Act (31 U.S.C. Section 3729 et seq.), the criminal False Claims Law (42 U.S.C. Section 1320a-7b(a)), all criminal Laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286 and 287, and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) (42 U.S.C. Section 1320d et seq.) as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.), the exclusion laws (42 U.S.C. Section 1320a-7), the civil monetary penalties law (42 U.S.C. Section 1320a-7a), (iii) Medicare (Title XVIII of the Social Security Act)&#59; (iv) Medicaid (Title XIX of the Social Security Act), (v) the Controlled Substances Act (21 U.S.C. Sections 801 et seq.), (vi) Healthcare Product Laws, including but not limited to HIPAA, relating to data privacy and the protection of personal information, including personal health information, and (vii) any and all other applicable health care laws and regulations. Except as otherwise disclosed in the Registration Statement and the Prospectus, neither the Company nor any of its subsidiaries has received written notice of any claim, action, suit, proceeding, hearing, enforcement, audit, investigation, arbitration or other action from any court, arbitrator, other Governmental Authority or third party alleging that any product, operation or activity of the Company or a subsidiary is in material violation of any Health Care Laws, and, to the Company&#8217;s knowledge, no such claim, action, suit, proceeding, hearing, enforcement, audit, investigation, arbitration or other action is threatened. Neither the Company nor any of its subsidiaries are a party to or have any ongoing reporting obligations pursuant to any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Regulatory Agency or other Governmental Authority. Neither the Company, any of its subsidiaries, any of their respective directors, officers, nor, to the Company&#8217;s knowledge, any of their respective employees or agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to an inquiry, investigation, proceeding, or other similar action by any Governmental Authority that would reasonably be expected to result in debarment, suspension, or exclusion.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(pp)&#160;&#160;&#160;&#160;The sale of the Placement Shares as contemplated hereby will not cause any holder of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(qq)&#160;&#160;&#160;&#160;Except as otherwise disclosed in the Registration Statement and the Prospectus, neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company&#8217;s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof, in each case except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(rr)&#160;&#160;&#160;&#160;No subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with respect to such subsidiary&#8217;s equity securities or from repaying to the Company or any other subsidiary of the Company any amounts that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring any property or assets to the Company or to any other subsidiary.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Any certificate signed by any officer of the Company and delivered to the Agent or its counsel in connection with the offering of the Placement Shares shall be deemed a representation and warranty by the Company, as to matters covered thereby, to the Agent.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Covenants of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company covenants and agrees with the Agent that&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Registration Statement Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  After the date of this Agreement and during any period in which the Prospectus relating to any Placement Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or a similar rule)&#59; (i) the Company will notify the Agent promptly of the time when any subsequent amendment to the Registration Statement, other than Incorporated Documents, has been filed with the Commission and&#47;or has become effective or any subsequent supplement to the Prospectus, other than Incorporated Documents, relating to the Placement Shares has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information relating to the offering of Placement Shares&#59; (ii) the Company will prepare and file with the Commission, promptly upon the Agent&#8217;s request, any amendments or supplements to the Registration Statement or Prospectus that, in the Agent&#8217;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by the Agent (provided, however, that the failure of the Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and provided, further, that the only remedy the Agent shall have with respect to the failure by the Company to make such filing (but without limiting the Agent&#8217;s rights under Section 9 hereof) will be to cease making sales under this Agreement until such amendment or supplement is filed)&#59; (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than Incorporated Documents, relating to the Placement Shares unless a copy thereof has been submitted to the Agent within a reasonable period of time before the filing and the Agent has not reasonably objected thereto (provided, however, that the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and provided, further, that the only remedy the Agent shall have with respect to the Company&#8217;s making such filing notwithstanding the Agent&#8217;s objection (but without limiting the Agent&#8217;s rights under Section 9 hereof) will be to cease making sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any Incorporated Document, except for those documents available via EDGAR&#59; and (iv) the Company will cause each amendment or supplement to the Prospectus, other than Incorporated Documents, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Notice of Commission Stop Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction or of the initiation or threatening of any proceeding for any such purpose&#59; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Delivery of Prospectus&#59; Subsequent Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  During any period in which the Prospectus relating to the Placement Shares is required to be delivered by the Agent under the Securities Act with respect to the offer and sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or a similar rule), the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and will file on or before their respective due dates (taking into account any extensions available under the Exchange Act) all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act.  If during such period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance.  </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Listing of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  During any period in which the Prospectus relating to the Placement Shares is required to be delivered by the Agent under the Securities Act with respect to the offer and sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or a similar rule), the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on Nasdaq.  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Delivery of Registration Statement and Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will furnish to the Agent and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all Incorporated Documents) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during any period in which the Prospectus relating to the Placement Shares is required to be delivered under the Securities Act (including all Incorporated Documents filed with the Commission during such period), in each case as soon as reasonably practicable and in such quantities as the Agent may from time to time reasonably request and, at the Agent&#8217;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent to the extent such document is available on EDGAR.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Earnings Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will make generally available to its security holders and to the Agent as soon as practicable, but in any event not later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a) of and Rule 158 under the Securities Act.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated in accordance with the provisions of Section 11 hereunder, will pay all expenses incident to the performance of its obligations hereunder, including expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of the Prospectus and of each amendment and supplement thereto and of this Agreement and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (ii) the preparation, issuance, sale and delivery of the Placement Shares and any taxes due or payable in connection therewith, (iii) the qualification of the Placement Shares under securities laws in accordance with the provisions of Section 7(w) of this Agreement, including filing fees (provided, however, that any fees or disbursements of counsel for the Agent in connection therewith shall be paid by the Agent), (iv) the printing and delivery to the Agent and its counsel of copies of the Prospectus and any amendments or supplements thereto, and of this Agreement, (v) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for trading on Nasdaq, (vi) the filing fees and expenses, if any, owed to the Commission or FINRA and the fees and expenses of any transfer agent or registrar for the Shares, (vii) the fees and associated expenses of the Agent&#8217;s outside legal counsel for filings with the FINRA Corporate Financing Department in an amount not to exceed $10,000 (excluding FINRA filing fees referred to in clause (vi) above and subject to the aggregate cap on fees and disbursements referred to in clause (viii) below), and (viii) the reasonable fees and disbursements of the Agent&#8217;s outside legal counsel (A) in an amount not to exceed $50,000 (inclusive of the fees and associated expenses referred to in clause (vii) above) arising out of executing this Agreement and the Company&#8217;s delivery of the initial certificate pursuant to Section 7(m) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and (B) in an amount not to exceed $10,000 in connection with each Representation Date (as defined below) on which the Company is required to provide a certificate pursuant to Section 7(m).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of Proceeds.&#8221;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Notice of Other Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Without the prior written consent of the Agent, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any shares of Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable or exercisable for shares of Common Stock, warrants or any rights to purchase or acquire shares of Common Stock during the period beginning on the fifth Trading Day immediately prior to the date on which any Placement Notice is delivered to Agent hereunder and ending on the first Trading Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">of such suspension or termination)&#59; and will not directly or indirectly in any other &#8220;at the market offering&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any shares of Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable or exercisable for shares of Common Stock, warrants or any rights to purchase or acquire, shares of Common Stock prior to the later of the termination of this Agreement and the thirtieth day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that such restrictions will not be required in connection with the Company&#8217;s issuance or sale of (i) shares of Common Stock, options to purchase shares of Common Stock, other securities under the Company&#8217;s existing equity incentive plans, or shares of Common Stock issuable upon the exercise of options or vesting of other securities, pursuant to any employee or director stock option , incentive or benefits plan, stock purchase or ownership plan, dividend reinvestment plan (but not shares of Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan), inducement award under the rules of Nasdaq or other compensation plan of the Company whether now in effect or hereafter implemented, (ii) shares of Common Stock issuable upon exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agent and (iii) shares of Common Stock or securities convertible into or exchangeable for shares of Common Stock as consideration for mergers, acquisitions, other business combinations, joint ventures or strategic alliances occurring after the date of this Agreement which are not issued for capital raising purposes.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Change of Circumstances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will, at any time during a fiscal quarter in which the Company intends to tender a Placement Notice or sell Placement Shares, advise the Agent as promptly as reasonably practicable prior to the delivery of such Placement Notice or sale of Placement Shares of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided or required to be provided to the Agent pursuant to this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Due Diligence Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by the Agent, its affiliates agents and counsel from time to time in connection with the transactions contemplated hereby, including providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#8217;s principal offices, as the Agent may reasonably request.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Required Filings Relating to Placement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company agrees that on or prior to such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act, which prospectus supplement will set forth, within the relevant period, the number or amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that, unless a prospectus supplement containing such information is required to be filed under the Securities Act, the requirement of this Section 7(l) may be satisfied by Company&#8217;s inclusion in the Company&#8217;s Form 10-K or Form 10-Q, as applicable, of the number or amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares during the relevant period.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Representation Dates&#59; Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On or prior to the date on which the Company first delivers a Placement Notice pursuant to this agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">First Placement Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and each time the Company&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares (other than a prospectus supplement filed in accordance with Section 7(l) of this Agreement) by means of a post-effective amendment, sticker or supplement but not by means of incorporation of document(s) by reference into the Registration Statement or the Prospectus relating to the Placement Shares&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;files an annual report on Form 10-K under the Exchange Act (including any Form 10-K&#47;A containing amended financial information or a material amendment to the previously filed Form 10-K but other than </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">an amendment thereto, if any, containing the information required by Part III of such previously filed Form 10-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">)&#59;</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iii)&#160;&#160;&#160;&#160;files a quarterly report on Form 10-Q under the Exchange Act&#59; or</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iv)&#160;&#160;&#160;&#160;files a current report on Form 8-K containing amended financial information (other than an earnings release that is &#8220;furnished&#8221; pursuant to Item 2.02 or Item 7.01 of Form 8-K) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Representation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the Company shall furnish the Agent (but in the case of clause (iv) above only if (1) a Placement Notice is pending or in effect and (2) the Agent requests such certificate within three Business Days after the filing of such Form 8-K with the Commission) with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented), within two Trading Days of any Representation Date.  The requirement to provide a certificate under this Section 7(m) shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending or in effect, which waiver shall continue until the earlier to occur of (1) the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and (2) the next occurring Representation Date.  Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date on which the Company relied on the waiver referred to in the previous sentence and did not provide the Agent with a certificate under this Section 7(m), then before the Company delivers a Placement Notice or the Agent sells any Placement Shares pursuant thereto, the Company shall provide the Agent with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, dated the date of such Placement Notice. Within two Trading Days of each Representation Date, the Company shall have furnished to the Agent such further information, certificates and documents as the Agent may reasonably request.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Legal Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On or prior to the First Placement Notice Date and on any date which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable, the Company shall cause to be furnished to the Agent the written opinion and negative assurance letter of O&#8217;Melveny &#38; Myers LLP, counsel to the Company, or such other counsel satisfactory to the Agent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Company Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), in form and substance satisfactory to the Agent and its counsel, dated the date that the opinion and negative assurance letter are required to be delivered, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that in lieu of such opinion and negative assurance letter for subsequent Representation Dates, Company Counsel may furnish the Agent with a letter to the effect that the Agent may rely on a prior opinion or negative assurance letter delivered by such counsel under this Section 7(n) to the same extent as if it were dated the date of such letter (except that statements in such prior opinion or negative assurance letter shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Representation Date).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On or prior to the First Placement Notice Date and on any date which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable, the Company shall cause its independent registered public accounting firm (and any other independent accountants whose report is included in the Registration Statement or the Prospectus) to furnish the Agent letters (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Comfort Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that if requested by the Agent, the Company shall cause a Comfort Letter to be furnished to the Agent within 10 Trading Days of the occurrence of any material transaction or event that necessitates the filing of additional, pro forma, amended or revised financial statements (including any restatement of previously issued financial statements) dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this Section 7(o).  Each Comfort Letter shall be in form and substance satisfactory to the Agent and each Comfort Letter from the Company&#8217;s independent registered public accounting firm shall (i) confirm that they are an independent registered public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) state, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings (the first such letter, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Initial Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and (iii) update the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Market Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will not, directly or indirectly, and will cause its officers, directors and subsidiaries not to (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">any security of the Company to facilitate the sale or resale of shares of Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Company may bid for and purchase shares of Common Stock in accordance with Rule 10b-18 under the Exchange Act.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company and its subsidiaries shall maintain, or cause to be maintained, insurance in such amounts and covering such risks as is reasonable and customary for the business for which it is engaged.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(r)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company and each of its subsidiaries shall maintain, or cause to be maintained, all material environmental certificates, authorizations or permits required by federal, state and local law in order to conduct their businesses as described in the Prospectus (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and the Company and each of its subsidiaries shall conduct their businesses, or cause their businesses to be conducted, in substantial compliance with such Permits and with applicable Environmental Laws, except where the failure to maintain or be in compliance with such Permits could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(s)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will not invest, or otherwise use the proceeds received by the Company from the sale of the Placement Shares in such a manner so as to require the Company or any of its subsidiaries to become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(t)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Securities Act and Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will use its best efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and the Prospectus. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(u)&#160;&#160;&#160;&#160;&#91;Reserved&#93;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Blue Sky and Other Qualifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Company will use its commercially reasonable efforts, in cooperation with the Agent, to qualify the Placement Shares for offering and sale, or to obtain an exemption for the Placement Shares to be offered and sold, under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Agent may designate and to maintain such qualifications and exemptions in effect for so long as required for the distribution of the Placement Shares (but in no event for less than one year from the date of this Agreement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. In each jurisdiction in which the Placement Shares have been so qualified or exempt, the Company will file such statements and reports as may be required by the laws of such jurisdiction to continue such qualification or exemption, as the case may be, in effect for so long as required for the distribution of the Placement Shares (but in no event for less than one year from the date of this Agreement).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(w)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will maintain and keep accurate books and records reflecting its assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company&#8217;s financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company are being made only in accordance with management&#8217;s and the Company&#8217;s directors&#8217; authorization, and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on its financial statements.  The Company will maintain disclosure controls and other procedures, including, without limitation, those required by Section 302 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information relating to the Company is made known to it by others within the Company, particularly during the period in which such periodic reports are being prepared..</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Emerging Growth Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company will promptly notify the Agent if the company ceases to be an Emerging Growth Company at any time prior to the completion of the Agent&#8217;s distribution of the Placement Shares pursuant to this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(y)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Renewal of Registration Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> If, immediately prior to the third anniversary of the initial effective date of the Registration Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Renewal Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), any of the Placement Shares remain unsold and this Agreement has not been terminated, the Company will, prior to the Renewal Date, file a new shelf registration statement or, if applicable, an automatic shelf registration statement relating to the Common Stock that may be offered and sold pursuant to this Agreement (which shall include a prospectus reflecting the number or amount of Placement Shares that may be offered and sold pursuant to this Agreement), in a form satisfactory to the Agent and its counsel, and, if such registration statement is not an automatic shelf registration statement, will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Date. The Company will take all other reasonable actions necessary or appropriate to permit the public offer and sale of the Placement Shares to continue as contemplated in the expired registration statement and this Agreement. From and after the effective date thereof, references herein to the &#8220;Registration Statement&#8221; shall include such new shelf registration statement or such new automatic shelf registration statement, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(z)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">General Instruction I.B.6. of Form S-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. If, from and after the date of this Agreement, the Company is no longer eligible to use Form S-3 (including pursuant to General Instruction I.B.6.) at the time it files with the Commission an annual report on Form 10-K or any post-effective amendment to the Registration Statement, then it shall promptly notify the Agent and, within two Business Days after the date of filing of such annual report on Form 10-K or amendment to the Registration Statement, the Company shall file a new prospectus supplement with the Commission reflecting the number of shares of Common Stock available to be offered and sold by the Company under this Agreement pursuant to General Instruction I.B.6. of Form S-3&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Company may delay the filing of any such prospectus supplement for up to 30 days if, in the reasonable judgment of the Company, it is in the best interest of the Company to do so, provided that no Placement Notice is in effect or pending during such time. Until such time as the Company shall have filed such prospectus supplement, the Company shall not notify the Agent to resume the offering of Placement Shares. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(aa)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Tax Indemnity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Company will indemnify and hold harmless the Agent against any documentary, stamp or similar issue tax, including any interest and penalties, on the issue and sale of the Placement Shares.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(bb)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Transfer Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Company has engaged and will maintain, at its sole expense, a transfer agent and registrar for the Common Stock.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Conditions to the Agent&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The obligations of the Agent hereunder with respect to a Placement will be subject to the due performance by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to the Agent in its reasonable judgment, and to the continuing satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Registration Statement Effective</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Registration Statement shall be effective and shall be available for all offers and sales of Placement Shares (i) that have been issued pursuant to all prior Placement Notices and (ii) that will be issued pursuant to any Placement Notice.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Company shall have filed with the Commission the Prospectus Supplement pursuant to Rule 424(b) under the Securities Act not later than the Commission&#8217;s close of business on the second Business Day following the date of this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">No Material Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  None of the following events shall have occurred and be continuing&#58; (i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus relating to the offering of the Placement Shares and that have not been complied with&#59; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose&#59; (iii) receipt by the Company or any of its subsidiaries of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose&#59; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material Incorporated Document untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or Incorporated Documents so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, in the case of the Prospectus, so that it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">No Misstatement or Material Omission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&#8217;s opinion is material, or omits to state a fact that in the Agent&#8217;s opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Material Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material Adverse Effect or any development that could reasonably be expected to result in a Material Adverse Effect, or any downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities), if any, by any rating organization, the effect of which, in the judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Company Counsel Legal Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent shall have received the opinions and negative assurance letters, as applicable, of Company Counsel required to be delivered pursuant to Section 7(n), on or before the date on which such delivery of such opinions and negative assurance letters are required pursuant to Section 7(n).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Agent&#8217;s Counsel Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent shall have received from Goodwin Procter LLP, counsel for the Agent, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to Section 7(n), with respect to such matters as the Agent may reasonably require, and the Company shall have furnished to such counsel such documents as they may request to enable them to pass upon such matters.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent shall have received the Comfort Letter required to be delivered pursuant to Section 7(o) on or before the date on which such delivery of such Comfort Letter is required pursuant to Section 7(o).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Representation Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent shall have received the certificate required to be delivered pursuant to Section 7(m) on or before the date on which delivery of such certificate is required pursuant to Section 7(m).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Secretary&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. On or prior to the First Placement Notice Date, the Agent shall have received a certificate, signed on behalf of the Company by the Secretary of the Company and attested to by an executive officer of the Company, dated as of such date and in form and substance satisfactory to the Agent and its counsel, certifying as to (i) the amended and restated certificate of incorporation of the Company, (ii) the amended and restated bylaws of the Company, and (iii) the resolutions of the board of directors of the Company or duly authorized committee thereof authorizing the execution, delivery and performance of this Agreement and the issuance and sale of the Placement Shares. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">No Suspension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Common Stock shall be duly listed, and admitted and authorized for trading, subject to official notice of issuance, on Nasdaq. Trading in the Common Stock shall not have been suspended on, and the Common Stock shall not have been delisted from, Nasdaq.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Other Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  On each date on which the Company is required to deliver a certificate pursuant to Section 7(m), the Company shall have furnished to the Agent such appropriate further information, opinions, certificates, letters and other documents as the Agent may have reasonably requested. All such information, opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof.  The Company shall have furnished the Agent with conformed</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">copies of such opinions, certificates, letters and other documents as the Agent may have reasonably requested.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Securities Act Filings Made</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  All filings with the Commission required by Rule 424(b) or Rule 433 under the Securities Act to have been filed prior to the Time of Sale with respect to any Placement Shares shall have been made within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on Rule 424(b)(8) of the Securities Act) or Rule 433, as applicable.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Approval for Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Either (i) the Placement Shares shall have been approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any objections thereto.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">FINRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  FINRA shall have raised no objection to the terms of the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">No Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant to Section 11(a).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Indemnification and Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Company Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company agrees to indemnify and hold harmless the Agent and its affiliates and their respective partners, members, directors, officers, employees and agents, and each person, if any, who controls the Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses and damages (including any and all investigative, legal and other expenses reasonably incurred in connection with, and any and all amounts paid in settlement (in accordance with this Section 9), any action, suit, investigation or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party (including any governmental or self-regulatory authority, or otherwise), to which the Agent, or any such other person may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus (or any amendment or supplement to the Registration Statement or the Prospectus) or in any free writing prospectus or (y) the omission or alleged omission to state in any such document a material fact required to be stated therein or necessary to make the statements therein (solely with respect to the Prospectus, in light of the circumstances under which they were made) not misleading&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that in each case this indemnity agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of the Placement Shares pursuant to this Agreement and is caused, directly or indirectly, by an untrue statement or omission, or alleged untrue statement or omission, made in reliance upon and in conformity with the Agent&#8217;s Information.  This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Agent Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 9(a), but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Agent&#8217;s Information.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  Any party that proposes to assert the right to be indemnified under this Section 9 will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 9, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this Section 9 and (ii) any liability that it may have to any indemnified party under the foregoing provision of this Section 9 unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any other legal expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating to such fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent.  No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Section 9 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an unconditional release of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all liability arising out of such claim, action or proceeding and (2) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Section 9 is applicable in accordance with its terms but for any reason is held to be unavailable or insufficient from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit, investigation or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Agent, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other hand. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation (before deducting expenses) received by the Agent from the sale of Placement Shares on behalf of the Company.  If, but </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action, suit, investigation or proceeding in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this Section 9(e) were to be determined by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action, suit, investigation or proceeding in respect thereof, referred to above in this Section 9(e) shall be deemed to include, for the purpose of this Section 9(e), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action, suit, investigation, proceeding or claim to the extent consistent with this Section 9.  Notwithstanding the foregoing provisions of this Section 9(e), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 9(e), any person who controls a party to this Agreement within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, any affiliates of the Agent, and any partners, members, directors, officers, employees and agents of the Agent will have the same rights to contribution as that party, and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this Section 9(e), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 9(e) except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of Section 9(c) hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to Section 9(c) hereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Representations and Agreements to Survive Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The indemnity and contribution agreements contained in Section 9 of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their respective officers, directors, employees or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;The Agent shall have the right, by giving notice as hereinafter specified, at any time to terminate this Agreement if (i) any Material Adverse Effect, or any development that could reasonably be expected to result in a Material Adverse Effect, has occurred that, in the judgment of the Agent, may materially impair the ability of the Agent to sell the Placement Shares hereunder, (ii) the Company shall have failed, refused or been unable to perform any agreement on its part to be performed hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, in the case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion or letter required under Section 7(m), Section 7(n), Section 7(o) or Section 7(p), the Agent&#8217;s right to terminate shall not arise unless such failure to deliver (or cause to be delivered) continues for more than 15 calendar days from the date such delivery was required, (iii) any other condition of the Agent&#8217;s obligations hereunder is not fulfilled, (iv) any suspension or limitation of trading in the Placement Shares or in securities generally on Nasdaq shall have occurred, (v) a general banking moratorium shall have been declared by any of United States federal or New York authorities, or (vi) there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or calamity, or any change in the United States or international financial markets that, in the judgment of the Agent, may materially impair the ability of the Agent to sell Placement Shares hereunder </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or to enforce contracts for the sale of securities. Any such termination shall be without liability of any party to any other party except that the provisions of Section 7(g), Section 9, Section 10, Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this Agreement as provided in this Section 11(a), the Agent shall provide the required notice as specified in Section 12.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;The Company shall have the right, by giving three days&#8217; prior notice as hereinafter specified, to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of Section 7(g), Section 9, Section 10, Section 11(f), Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)The Agent shall have the right, by giving three days&#8217; prior notice as hereinafter specified, to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of Section 7(g), Section 9, Section 10, Section 11(f), Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Unless earlier terminated pursuant to this Section 11, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agent on the terms and subject to the conditions set forth herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that the provisions of Section 7(g), Section 9, Section 10, Section 11(f), Section 16 and Section 17 hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;This Agreement shall remain in full force and effect unless terminated pursuant to Sections 11(a), (b), (c), or (d) above or otherwise by mutual agreement of the parties&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that any such termination by mutual agreement shall in all cases be deemed to provide that Section 7(g), Section 9, Section 10, Section 11(f), Section 16 and Section 17 shall remain in full force and effect.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;Any termination of this Agreement shall be effective on the date specified in such notice of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement. Upon termination of this Agreement, the Company shall not be required to pay to the Agent any discount or commission with respect to any Placement Shares not otherwise sold by the Agent under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Company shall remain obligated to reimburse the Agent&#8217;s expenses pursuant to Section 7(g).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified in this Agreement, and if sent to the Agent, shall be delivered to&#58;</font></div><div><font><br></font></div><div style="text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SVB Leerink LLC</font></div><div style="text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1301 Avenue of the Americas, 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Floor</font></div><div style="text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">New York, New York  10019</font></div><div style="text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Attention&#58; Peter M. Fry</font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E-mail&#58; peter.fry&#64;svbleerink.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">with a copies (which shall not constitute notice) to&#58;</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SVB Leerink LLC</font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1301 Avenue of the Americas, 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Floor</font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">New York, New York  10019</font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Attention&#58; Stuart R. Nayman, Esq.</font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E-mail&#58; stuart.nayman&#64;svbleerink.com</font></div><div><font><br></font></div><div style="padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Goodwin Procter LLP</font></div><div style="padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">620 Eighth Avenue</font></div><div style="padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">New York, New York 10018</font></div><div style="padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Attention&#58; Seo Salimi, Esq.</font></div><div style="padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E-mail&#58; seo.salimi&#64;goodwinlaw.com</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and if to the Company, shall be delivered to&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">520 Newport Center Drive, Suite 1200</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Newport Beach, California 92660</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Attention&#58; Chief Financial Officer</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E-mail&#58; lauren.silvernail&#64;evolus.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">with copies (which shall not constitute notice) to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">O&#8217;Melveny &#38; Myers LLP<br>610 Newport Center Drive, Suite 1700</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Newport Beach, California 92660</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Attention&#58; Mark Peterson, Esq. and Shelly Heyduk</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E-mail&#58; mpeterson&#64;omm.com and sheyduk&#64;omm.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.  Each such notice or other communication shall be deemed given (i) when delivered personally, (ii) by Electronic Notice as set forth in the next paragraph, (iii) on the next Business Day after timely delivery to a nationally-recognized overnight courier or (iv) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean any day on which the Nasdaq and commercial banks in the City of New York are open for business.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">An electronic communication (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Electronic Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) shall be deemed written notice for purposes of this Section 12 if sent to the electronic mail address specified by the receiving party in Section 12. Electronic Notice shall be deemed received at the time the party sending Electronic Notice receives actual acknowledgment of receipt from the person to whom the notice is sent, other than via auto-reply. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Nonelectronic Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), which shall be sent to the requesting party within 10 days of receipt of the written request for Nonelectronic Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that such request for a Nonelectronic Notice shall not affect the time on which any written notice delivered pursuant to this Section 12 is deemed to be given.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers, directors and other persons referred to in Section 9 hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of each such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto, the persons referred to in the preceding sentence and their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that the Agent may assign its rights and obligations hereunder to an affiliate of the Agent without obtaining the Company&#8217;s consent, so long as such affiliate is a registered broker-dealer.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Adjustments for Share Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Entire Agreement&#59; Amendment&#59; Severability&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  This Agreement (including all schedules (as amended pursuant to this Agreement) and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> of this Agreement may be amended by either party from time to time by sending a notice containing a revised </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> to the other party in the manner provided in Section 12 and, upon such amendment, all references herein to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> shall automatically be deemed to refer to such amended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  In the event that any one or more of the provisions contained herein, or the application </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.  No implied waiver by a party shall arise in the absence of a waiver in writing signed by such party. No failure or delay in exercising any right, power, or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power, or privilege hereunder.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">GOVERNING LAW AND TIME</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Consent to Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">for the adjudication of any dispute hereunder or in connection with any of the transactions contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum, or that the venue of such suit, action or proceeding is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy (certified or registered mail, return receipt requested) to such party at the address in effect for notices under Section 12 of this Agreement and agrees that such service shall constitute good and sufficient notice of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%"> </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;The section and exhibit headings herein are for convenience only and shall not affect the construction hereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;Words defined in the singular shall have a comparable meaning when used in the plural, and vice versa. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;The words &#8220;hereof,&#8221; &#8220;hereto,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Wherever the word &#8220;include,&#8221; &#8220;includes&#8221; or &#8220;including&#8221; is used in this Agreement, it shall be deemed to be followed by the words &#8220;without limitation.&#8221;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;References herein to any gender shall include each other gender.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;References herein to any law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority shall be deemed to refer to such law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority as amended, reenacted, supplemented or superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated thereunder.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Permitted Free Writing Prospectuses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. Each of the Company and the Agent represents, warrants and agrees that, unless it obtains the prior written consent of the other party, which consent shall not be unreasonably withheld, conditioned or delayed, it has not made and will not make any offer relating to the Placement Shares that would constitute an issuer free writing prospectus, or that would otherwise constitute a free writing prospectus (as defined in Rule 405), required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company, as the case may be, is hereinafter referred to as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Permitted Free Writing Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.&#8221;  The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus, and that it has complied and will comply with the requirements of Rule 433 </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Absence of Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Company acknowledges and agrees that&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;the Agent has been retained to act as sales agent in connection with the sale of the Placement Shares, the Agent has acted at arms&#8217; length and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and the Agent, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Agent has advised or is advising the Company on other matters and the Agent has no duties or obligations to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth herein&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;the Company is capable of evaluating, and understanding and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;neither the Agent nor its affiliates have provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;the Company has been advised and is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that the Agent and its affiliates have no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;except in connection with any breach of Section 23 hereof, the Company waives, to the fullest extent permitted by law, any claims it may have against the Agent or its affiliates for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the transactions contemplated by this Agreement and agrees that the Agent and its affiliates shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including stockholders (or other equity holders), creditors or employees of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Recognition of the U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  In the event that the Agent is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from the Agent of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">In the event that the Agent is a Covered Entity and the Agent or a BHC Act Affiliate of the Agent becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">For purposes of this Agreement, (A) &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k)&#59; (B) &#8220;Covered Entity&#8221; means any of the following&#58; (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b)&#59; (C) &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable&#59; and (D) &#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic </font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">transmission. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Use of Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.  The Agent may not provide any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to any third party other than its legal counsel advising it on this Agreement and the transactions contemplated by this Agreement unless expressly approved by the Company in writing.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Agent&#8217;s Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. As used in this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Agent&#8217;s Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means solely the following information in the Registration Statement and the Prospectus&#58; the eighth paragraph under the heading &#8220;Plan of Distribution&#8221; in the Prospectus Supplement. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR.  All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">All references in this Agreement to &#8220;supplements&#8221; to the Prospectus shall include any supplements, &#8220;wrappers&#8221; or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#91;Remainder of Page Intentionally Blank&#93;</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div id="i96a9a857120a46ab9ef2c67d5069d10d_76"></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EVOLUS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; David Moatazedi                 </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; David Moatazedi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ACCEPTED as of the date</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">first-above written&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SVB LEERINK LLC</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Jon Civitarese                </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Jon Civitarese</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; Managing Director</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:252pt"><font><br></font></div><div id="i96a9a857120a46ab9ef2c67d5069d10d_71"></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SCHEDULE 1</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">FORM OF PLACEMENT NOTICE</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">From&#58;               &#91;                                     &#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">                        &#91;TITLE&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">                        Evolus. Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cc&#58;                   &#91;                                     &#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">To&#58;                   SVB Leerink LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Subject&#58;            SVB Leerink&#8212;At the Market Offering&#8212;Placement Notice</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated March 26, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), by and between Evolus, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and SVB Leerink LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SVB Leerink</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), I hereby request on behalf of the Company that SVB Leerink sell up to $&#91;&#9679;&#93; million of shares of common stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), at a minimum market price of $      per share&#91;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that no more than &#91;  &#93; Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)&#93;.  Sales should begin &#91;on the date of this Placement Notice&#93; and end on &#91;DATE&#93; &#91;until all Shares that are the subject of this Placement Notice are sold&#93;.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div id="i96a9a857120a46ab9ef2c67d5069d10d_66"></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SCHEDULE 2</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">The Company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">lauren.silvernail&#64;evolus.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">david.moatazedi&#64;evolus.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SVB Leerink </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">jon.civitarese&#64;svbleerink.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ATM&#64;svbleerink.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i96a9a857120a46ab9ef2c67d5069d10d_61"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">SCHEDULE 3</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Compensation</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company shall pay SVB Leerink compensation in cash equal to 3.0% of the gross proceeds from the sales of Placement Shares pursuant to the terms of the Sales Agreement of which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> forms a part.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i96a9a857120a46ab9ef2c67d5069d10d_81"></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit 7(m)</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">OFFICERS&#8217; CERTIFICATE</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Each of &#91;&#9679;&#93;, the duly qualified and elected Chief Executive Officer of Evolus, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and &#91;&#9679;&#93;, the duly qualified and elected Chief Financial Officer of the Company, does hereby certify in his or her respective capacity and on behalf of the Company, pursuant to Section 7(m) of the Sales Agreement, dated March 26, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Sales Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), by and between the Company and SVB Leerink LLC, that, after due inquiry, to the best of the knowledge of the undersigned&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;The representations and warranties of the Company in Section 6 of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Effect, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions relating to materiality or Material Adverse Effect, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iii)&#160;&#160;&#160;&#160;As of the date hereof, (A) the Registration Statement complies in all material respects with the requirements of the Securities Act and does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading, (B) the Prospectus complies in all material respects with the requirements of the Securities Act and does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (C) no event has occurred as a result of which it is necessary to amend or supplement the Registration Statement or the Prospectus in order for clauses (A) and (B) above to be true and correct.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iv)&#160;&#160;&#160;&#160;There has been no material adverse change, or any development that could reasonably be expected to result in a material adverse change, in the condition (financial or otherwise), business, properties, operations, assets, liabilities or prospects of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, since the date as of which information is given in the Prospectus, as amended or supplemented to the date hereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(v)&#160;&#160;&#160;&#160;The Company does not possess any material non-public information with respect to the Company and its subsidiaries, taken as a whole. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(vi)The maximum amount of Placement Shares that may be sold pursuant to the Sales Agreement has been duly authorized by the Company&#8217;s board of directors or a duly authorized committee thereof pursuant to a resolution or unanimous written consent in accordance with the Company&#8217;s amended and restated articles of incorporation, amended and restated bylaws and applicable law.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Sales Agreement.</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, each of the undersigned, in such individual&#8217;s respective capacity as Chief Executive Officer or Chief Financial Officer of the Company, has executed this Officers&#8217; Certificate on behalf of the Company. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">                                                </font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Name&#58;</font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Title&#58; Chief Executive Officer</font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Date&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">                                                </font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Name&#58;</font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Title&#58; Chief Financial Officer</font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      Date&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5132621.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i837f87a20d0a4f95bf254f4f0094c0cc_33"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><img alt="image1a.jpg" src="image1a.jpg" style="height:23px;margin-bottom:5pt;vertical-align:text-bottom;width:119px"></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">O&#8217;Melveny &#38; Myers LLP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T&#58; +1 949 823 6900</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">File Number&#58; 0252827-00011</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610 Newport Center Drive</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F&#58; +1 949 823 6994</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17th Floor</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">omm.com</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newport Beach, CA 92660</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">March 26, 2021</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Evolus, Inc.<br>520 Newport Center Drive, Suite 1200 <br>Newport Beach, CA 92660  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Re&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">At-the-Market Offering of up to $75,000,000 of Common Stock of Evolus, Inc.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have acted as special counsel to Evolus, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), in connection with the offer and sale from time to time by the Company of the Company&#8217;s common stock, par value $0.00001 per share, having an aggregate offering price of up to $75,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), under the prospectus supplement, dated March 26, 2021, to the prospectus, dated April 15, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Shares are being offered and sold pursuant to a Registration Statement on Form S-3 (File No. 333-230466), including the amendment thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), initially filed by the Company with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on March 22, 2019, amended on April 10, 2019 and declared effective by the Commission on April 15, 2019. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In rendering the opinion below, we examined originals or copies of those corporate and other records and documents we considered appropriate. We assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity with originals of all documents submitted to us as copies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Based on this examination, we are of the opinion that the issuance of the Shares have been duly authorized by all necessary corporate action on the part of the Company and, upon payment for and delivery of the Shares in accordance with the Sales Agreement, the Shares will be validly issued, fully paid and non-assessable. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The law governed by this opinion letter is limited to the present General Corporation Law of the State of Delaware. We express no opinion herein as to any other laws, statutes, regulations or ordinances of any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act of 1933, as amended, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the prospectus included in the Registration Statement or any prospectus supplement, other than as expressly stated herein with respect to the Shares. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We hereby consent to the use of this opinion as an exhibit to a Current Report on Form 8-K and the incorporation by reference of this opinion as an exhibit to the Registration Statement and to the reference to this firm under the heading &#8220;Legal Matters&#8221; in the Prospectus Supplement. This opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters. This letter speaks only as of the date hereof and we assume no obligation to update or supplement this opinion to reflect any facts or circumstances that arise after the date of this opinion and come to our attention, or any future changes in laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Century City</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Los Angeles</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Newport Beach</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">New York</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">San Francisco</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Silicon Valley</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Washington, DC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Beijing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Brussels</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Hong Kong</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">London</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Seoul</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Shanghai</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Singapore</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Tokyo</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><img alt="image1a.jpg" src="image1a.jpg" style="height:23px;margin-bottom:5pt;vertical-align:text-bottom;width:119px"></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:14.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Respectfully submitted,<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; O&#8217;Melveny &#38; Myers LLP<br></font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>eols-20210326.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:eols="http://www.evolus.com/20210326" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.evolus.com/20210326">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20210326_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20210326_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20210326_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20210326_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.evolus.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>eols-20210326_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.evolus.com/role/CoverPage" xlink:type="simple" xlink:href="eols-20210326.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.evolus.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>eols-20210326_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.evolus.com/role/CoverPage" xlink:type="simple" xlink:href="eols-20210326.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.evolus.com/role/CoverPage" xlink:type="extended" id="i223b18333fe146e3b0efa547b5ccd456_CoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>eols-20210326_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_3026a04c-a4ac-41f5-9292-034a1c3b9660_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_9972a326-7c19-4daa-9dd1-3b0f50c2d967_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_85157671-e806-4741-8f2b-2aaae8e5802f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b42f7655-fdda-433b-a73e-f02f65b98b45_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_14b5e80d-27f3-47ef-af9a-2fce01f64a03_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9bd95971-80b6-4251-8c34-79daf402b3a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_14e2013c-b91a-4259-93cc-a19133e80ee1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fddd0965-2636-4ed8-8324-4e7414bfcc18_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6460781e-e657-43cc-825e-4aa84532e486_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_da7aa5b4-44df-435a-8ebf-0e143cb161a7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1cd8a765-8e7d-4db6-9448-ced5c878d2c1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4a44fa92-6c51-4610-b9d1-1e29d55bbd04_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_6a22938f-2280-401c-8ad4-26825f2cdcc9_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f4a60b92-af91-415b-bbaa-d88d61db4b63_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_44cc3d41-1605-43bb-8e9e-037723fe9a64_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8483da95-39ed-4394-bb36-98be61462de6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3fc39e4d-c2eb-432d-9ae0-c1762e52c8c6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7759e90b-9271-4605-bd65-bd7c62e1ed42_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c9f0b8de-063e-45f7-a173-cfc89df530e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_48390984-8bc4-4452-8007-3cfa61654f86_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d7b9df2b-e2e8-42e6-811d-cca61bfbf6a6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_943c0a5c-3544-4130-9845-1e0110d63fe9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_04dc1de4-fa29-45ad-a94f-c22e9403d1eb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>eols-20210326_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:66cd287d-5164-47df-a958-0a9970a0fc89,g:4ecb20a4-87d9-4291-8dff-a832e0a31642-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.evolus.com/role/CoverPage" xlink:type="simple" xlink:href="eols-20210326.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.evolus.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_abdb0b40-644b-4be4-9667-7bf3591e17c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_DocumentType_abdb0b40-644b-4be4-9667-7bf3591e17c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2a440251-e0e2-4daa-8aa2-1986328bb84f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_DocumentPeriodEndDate_2a440251-e0e2-4daa-8aa2-1986328bb84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_603d32f4-4784-4f06-b5a5-91afe43d5f14" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityRegistrantName_603d32f4-4784-4f06-b5a5-91afe43d5f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8188e6e9-6c37-40ab-89a0-264ed9b8d95c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8188e6e9-6c37-40ab-89a0-264ed9b8d95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f8bd85d3-3320-4549-91d4-a43a0c2bdd41" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityFileNumber_f8bd85d3-3320-4549-91d4-a43a0c2bdd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_56339398-4e85-4a2b-b5e3-910b97151030" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityTaxIdentificationNumber_56339398-4e85-4a2b-b5e3-910b97151030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4ea5a867-2fe9-4d37-ae4c-dda01e2715f5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityAddressAddressLine1_4ea5a867-2fe9-4d37-ae4c-dda01e2715f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c84ec356-f6a9-4f9d-8a53-e805f76d5d76" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityAddressCityOrTown_c84ec356-f6a9-4f9d-8a53-e805f76d5d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_482cb858-eb6a-4312-ab9c-e1d9ebb5beca" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityAddressStateOrProvince_482cb858-eb6a-4312-ab9c-e1d9ebb5beca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c5741356-1ca7-42cf-aed1-1c156a727887" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityAddressPostalZipCode_c5741356-1ca7-42cf-aed1-1c156a727887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6716ea8c-0214-4754-aecd-e8dce4fef90d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_CityAreaCode_6716ea8c-0214-4754-aecd-e8dce4fef90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8ef963b7-7c66-4c5c-8188-59ea8e898cec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_LocalPhoneNumber_8ef963b7-7c66-4c5c-8188-59ea8e898cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_f4516e74-547b-4887-af43-4c50f0d8717b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_WrittenCommunications_f4516e74-547b-4887-af43-4c50f0d8717b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_975a2c3b-6865-45cc-a2be-192de46a2450" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_SolicitingMaterial_975a2c3b-6865-45cc-a2be-192de46a2450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_560b1c7b-b771-489d-868d-e61a3189ed4d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_PreCommencementTenderOffer_560b1c7b-b771-489d-868d-e61a3189ed4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4a160638-ff9a-4919-ba76-be41726c5364" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4a160638-ff9a-4919-ba76-be41726c5364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e9fad223-fa4f-49fe-b67a-ed9810f7666e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_Security12bTitle_e9fad223-fa4f-49fe-b67a-ed9810f7666e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_96d57ed0-67a8-4169-9e52-3b275f491ad2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_TradingSymbol_96d57ed0-67a8-4169-9e52-3b275f491ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_375a9acb-3e4e-4fbe-85ea-a27260e5e880" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_SecurityExchangeName_375a9acb-3e4e-4fbe-85ea-a27260e5e880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ff681cda-f348-4c46-a9f3-18b476124ef7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityEmergingGrowthCompany_ff681cda-f348-4c46-a9f3-18b476124ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_03cf8988-4861-4339-8d37-ce23fd30a54f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityExTransitionPeriod_03cf8988-4861-4339-8d37-ce23fd30a54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_06b6f7cb-b3e4-4303-a969-20522e5a93ae" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_EntityCentralIndexKey_06b6f7cb-b3e4-4303-a969-20522e5a93ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_df75616d-b0ec-4c2f-a910-a66775302b6a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a445c419-0a8c-4386-a798-35b6bd0aaff6" xlink:to="loc_dei_AmendmentFlag_df75616d-b0ec-4c2f-a910-a66775302b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image1a.jpg
<TEXT>
begin 644 image1a.jpg
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MSOT_VCX'=7;E:ELE( (@(@&<KNEG'%T11NN;PW<VXN/Q'L!]7^Z',M>!9;Z
M;1W_]P^DR[9\QF^"2/U9^_SYZQT&F((DZ>&[/ZM?+3BRAK"@'WM1H@Y$(XVR
MEHD1Y&@D>^8S2>1.34UE*FU?!-4S$Q]<(% ;Y-"E>UHGEZK@8^BR#I<3!HG*
MH.@'ZU[=V>O9B17,@XWU!)[O 0+HQ_[;'__893'ZRB36RLC$OZR?/@2[OD\/
M5L:=0_244(T[R";&%;YW12YM32*H9(<<)OI=?*-^\D9?Y'K%H9\2%\4)UGCT
M@SG1%M5"P<"X!YO <__IBX!S=O&,$^"^-^9!G-:B]7&J#A(S,WYE>/500#"O
M(<U9A"LK1ZWU@3\<HD0N);HF&:AZ1[$VW\:(?R.K;,H_6I$;P<W6]8@GB)',
M#_K)-E^';)8XX +/;<?@U#P'7?;<ELB3/JW[AS\2?_UX\#E>Z%/*)3UR,3RN
M.+G\>E43=UJD.4!:V_4 '''016XLR:Z3W9/%B-N7'_3'[% PT._VM+X3Y^.U
M>^W/R<V"POW#EH1*X+85+*Y/L*@*,*_Q=UJVF(S76B_+W-?$G1"H[K#Z:+4)
M?9;IF5;@9C]PN%Z\E_W,#_GLV4%)!2A_GSEX[F=<*WMF7<3)5170^K3N'W9<
M?*Z^,KSR:@W-Z1VH,!85I%AK=:":FYNKJ;3][K2 9L"=\VST4Z&#)7+='J#K
MM^=:JW>BSW,_\ 4=7XOL\%.R*@FZGKF 7EM7_7KM.$'CDDO)=?_\F6",!^*&
M#L#Q23AT$N%3"%)G9F;*[N[P;[XU4#GH^-JZUP$(/]1'*W(!WOOCQIA'Y@M<
M'6AJ?FB_?@AS(B)X7CD\$&6'K-?:M/+/;8Y++K;=/_],]!.Y?&B/MQX! ,9&
M'%PIQW9U=;7]3]%QQ#*O!BJ;=I)TKTAGKOIH12[S\%-C\03I)1\=?6[5_-#>
MO S+-FT$+V(F^[+C58CYVL]IR8U!+1^SA.R^7>)ID4F4'DZEV2?2WOT'[3\3
MM)GCVB%0O?2Q;HQH;8!6Y+*>'\@8(X,@.=KSK!OR YMD7*QDV%99]WW&=<"+
MC/;L8B[/DM.2F_F750[6Z\CE 2*SC>$@_3A&!.ND)H=/T@Z!&J,Q9@'KZW)R
MV:A_ITLGMN[OD!_:1PP:)T<ZM%2/2'!<F]*IK&7.:<G%1JP*/&?2(Q<% $,9
M$HD(G.7@P28 1N^.S-A0'V6#^5S1&=;4&&VL%#ZF$[2O1591>0 .7[FX)XL<
M6.8,^2&;[-'7S+)6NK0$#Q6#-:D29##WO-KB7@A.V?9 E3WW#[U,_)7@52GJ
M'B$W*DR>SQX"7BWB6<.]G9#K:)SA>V6[?X)15;-*IFU,R!429[B-)W^]UWGM
M#,F$W"%TSLA8/$#QGN6,P5EE2";D#J'SE(_] T3@'.% _P@P     $E%3D2N
#0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>eols-20210326_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eols-20210326.xsd" xlink:type="simple"/>
    <context id="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001570562</identifier>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF80L2ZyYWc6NGZiYWEyYzc5MGRjNGEzZTg2YjdlOWJiM2Y4NGU2MTEvdGFibGU6MzYyNmVkMmNhMThmNDI0ZGJjNmVlNjIxMmU4M2U0ZTYvdGFibGVyYW5nZTozNjI2ZWQyY2ExOGY0MjRkYmM2ZWU2MjEyZTgzZTRlNl8yLTEtMS0xLTA_b30f32bf-0784-43b5-99c6-a1979a7b8e6d">0001570562</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF80L2ZyYWc6NGZiYWEyYzc5MGRjNGEzZTg2YjdlOWJiM2Y4NGU2MTEvdGFibGU6MzYyNmVkMmNhMThmNDI0ZGJjNmVlNjIxMmU4M2U0ZTYvdGFibGVyYW5nZTozNjI2ZWQyY2ExOGY0MjRkYmM2ZWU2MjEyZTgzZTRlNl81LTEtMS0xLTA_59195bf0-738e-42b9-a687-596f78afb2c8">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI5_4bfc6fcf-60ab-4802-ad04-85f4812377c2">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8yMjc_97ab0a8b-86fc-4b24-a122-b035c67fae14">2021-03-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMw_09b8950b-63ea-4595-85a4-5b737c401199">EVOLUS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTAtMS0xLTA_d8f3c312-365b-473c-b08e-4a575dc0234f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTItMS0xLTA_fab0fd29-89a8-45ac-9f1c-52373294f26f">001-38381</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjlmZTFjZTViNzQwNDY4YWFlNWIwNDg3YTM0ZGJjNzEvdGFibGVyYW5nZToyOWZlMWNlNWI3NDA0NjhhYWU1YjA0ODdhMzRkYmM3MV8wLTQtMS0xLTA_783df5ab-3923-4161-b6ab-1659b21d7ff2">46-1385614</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIx_c9358455-c388-4990-9319-d9bb2d37679b">520 Newport Center Drive, Suite 1200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM2_eb79cc37-5a9b-4f7a-9bd7-167865dbe820">Newport Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMx_3c88c229-ae62-4c49-8d2e-c007cd07193a">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzMy_980e88e9-e46e-4307-8e8c-e42380b68b3c">92660</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIy_d5eca46e-95b6-4d2a-b790-0c77fd0dfd4d">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM3_bcac74f4-7b75-4edb-ab8a-d86d0e9aa861">284-4555</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM5_0516c917-1b6b-408a-bc6d-3537c5957dc6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzIw_a237d3fa-aee1-454d-bb29-7ab2616c600b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI2_c31c91ef-bcc9-4bf3-aec8-aef4199d5577">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM1_28e041f0-6289-4387-8eb9-4025883ca04f">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTAtMS0xLTA_7ce63da9-68b7-45bc-a138-153d4da49062">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTEtMS0xLTA_3288e5bc-f7cb-46be-81bc-197f95fe4534">EOLS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGFibGU6MjUyOTNjM2RlYWU5NDYwZDk4MDExZjQzYmZlZDdlMjQvdGFibGVyYW5nZToyNTI5M2MzZGVhZTk0NjBkOTgwMTFmNDNiZmVkN2UyNF8xLTItMS0xLTAvdGV4dHJlZ2lvbjpiNGQ5YWIzMDU2YmU0NjIxODk2MjYyYmQwMGZlNjliZF80_470032b0-9cee-4c20-9306-9896460a97f6">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzI4_e556b972-e999-49ce-ab12-b3fc6ee4ead8">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i61df6299965744b181788e0ec12ebfc9_D20210326-20210326"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4Nzk1YmUyN2RlYTRhOGJiOTYwOGNhMjA2OGU0YTc4L3NlYzoxODc5NWJlMjdkZWE0YThiYjk2MDhjYTIwNjhlNGE3OF8xL2ZyYWc6YjE4MjYxYjE1ZjU3NGJmZGE2MDg0Mzg1ZWVmNmFiNDEvdGV4dHJlZ2lvbjpiMTgyNjFiMTVmNTc0YmZkYTYwODQzODVlZWY2YWI0MV8xNzM0_866a3af5-6e7b-41d5-a230-836bdeb34cc9">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140180683357320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 26,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EVOLUS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-1385614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">520 Newport Center Drive, Suite 1200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newport Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">284-4555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EOLS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001570562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"  61'I2EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ %D1Z4@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  6
M1'I2LH;5P.\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  61'I2F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !9$>E*^A<Z:
M4 0  -L0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  61'I2GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="eols-20210326.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.evolus.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="eols-20210326.htm">eols-20210326.htm</File>
    <File>eols-20210326.xsd</File>
    <File>eols-20210326_cal.xml</File>
    <File>eols-20210326_def.xml</File>
    <File>eols-20210326_lab.xml</File>
    <File>eols-20210326_pre.xml</File>
    <File>ex11032621.htm</File>
    <File>ex5132621.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "eols-20210326.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "eols-20210326_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "eols-20210326_def.xml"
     ]
    },
    "inline": {
     "local": [
      "eols-20210326.htm"
     ]
    },
    "labelLink": {
     "local": [
      "eols-20210326_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eols-20210326_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "eols-20210326.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "eols",
   "nsuri": "http://www.evolus.com/20210326",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eols-20210326.htm",
      "contextRef": "i61df6299965744b181788e0ec12ebfc9_D20210326-20210326",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.evolus.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eols-20210326.htm",
      "contextRef": "i61df6299965744b181788e0ec12ebfc9_D20210326-20210326",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001570562-21-000102-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001570562-21-000102-xbrl.zip
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MWZ"G4I?/'44"^4Q=$,N.):BVJP!Y.R;\SU4ERR*:9AAW$#4 5'#F('JGI):
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M$E[L?QJ!R<$@07J%-7GUVIO%+U!+ P04    "  61'I2=DRZ.0H"  !W!@
M%0   &5O;',M,C R,3 S,C9?9&5F+GAM;*V476_:,!2&[_D57G8[X\3Y($%
MI3%-FL2DB:UJ[R;'/B$628QL4^B_GY,"A=*JTIJ;*#Y^SWN>8UMG<K.O*_0
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MQ#O! P<[=S]T+]U_;QSL_!]02P,$%     @ %D1Z4GWK(,,3J@  @%<$  X
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M&C8)LQ><DF.KN"A:-(1@P711[)?UB=2E2O$KWB"-34ZH9%F(+D[+!1I&S9'
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M624-4$.Q&FBD!&\J'A@E(>!UKX^A>Z5].(J$V*)4,T2$Y=(DE%'9%:NLY+^
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M*W-Z1K4%KT'#O6F;!80WT?ZSP7U$,8**_CN;<J_LO2$8A,7<Y1;UP_FQL7)
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M'H%_232>J'KS#2C?2U?0HBI=%Y C+HF1$(M6[;T+^*94PX;H&R9?"H@]/0<
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MP"=V7)Q1[? P.48V.0Z:-VW1?7P9TB%#)\NQ6B+M($;!4 H'+J!XF[=?03Q
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M+]F;H#R,&6GLO;X%2"4E,GMF.1E\)JP]2WPD,XC)[("?>2YQ4C"=*-*XKH@
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MA4[3KR@L9:ZQ<\!T8S>1+AU0H_-OWM)-1L\OC\VO,/70=_2TG)YN/2T(DT:
MX@)1%7FQ:D[:; U>CNDFNJ>FA.B*V"Y]A-9"_3LG?*G0,L$+8>LEHQ>;3>MJ
MP%:&!8O9B=*$1RG)-I,@818";NC8RJC-P$?.8Y2ZHQG'/URT.,>9SDA7U,ZY
M%+8E1O7B&_,#4@J7G_*.2DI9?K9@K]YI]AY^6U5GJAH5*^N$^M&\68KU=4YM
MF99 -JD9E]V1[+TXS:KE]:#YZC6B9F\[1ZRN1I\(*?&.YNI10N#8Y3';3N2C
MU$O<M.N&."TQ*>L'7&SJ*KM8;BJF6'?XIY,2(=54-T5Q#3O;W7<P;4JDO .L
M8$F'V4UT%^@.]V>X!;=!B[_D.F/&=TG7Y\T*X20+,]"3=ZE$92%QK'97Z!\F
MPF1<MK\?OB-V$_K\LX9I)=\HYZ"IL3^YCC<]7;'=^WS63\_>[$G1MO%C"UC?
M#416T5(2W6H%*(9H=5&3'D9\RU3/B@FO$'+D>#+5M_[UQ;/G(!MNED"#DK*:
MLX#_B"YN2P=.Q>@-EC 7R:\B??1(4AD5.I4?U>%_;SSZ5#@J5V@"<L(0@5>$
MZ1Z?MM&[H5P^N']T7]_G[S6U6?P-GBC'@@)<Z2O&8Y\Q'@.YP\YY4D7@.I:P
M&KS+!,2F?HMSUI8I.\H\J;DM\+^^H1'=&\H-,:B,&6I:5$69F9+C%"OW\E._
M34(WC.AS*0_MQ";7%G/"JX/"AH<D!NQJ0^(K*CQ-SLK%&3$/C^^D:KYI_4UW
M4OG,,#)0^%9W^/K7U0U$)E+:"AP<SVFW5<5S.[)449XQ\K\0'.*"(51.+BJ1
M_O<=1,6WKVJ_33&8A.M:>0AH@3C#G+@K;6:;22Q3:0+2B:\3977T$4K$>9@O
MZN]R^VXNB71'_=3??MM:1G-LWSO2>[<NWZOT/*;GR1 !IS$1BK:P,FW165&L
MN:4C%^(C;L.S$&1SU)EA2Y^8:"H7_,AJZJS]@K!+K^C=IONAVT2(^Z8N(-K.
MR*KAIPE&+;VRYN&#L1GI;MZ6GII8Q[7AG\;+I,$UX(,G&PCE<6]Q$8@C+W48
MZD(@ L)0X-J_)]A*;IO3]PMMR:MP2_;!"Y0J_Q4@:3(:: .V[<FU\Z6Q*D]T
MH8C;=XS2WV9!%*1_1]7AV=EM"-L_/6 O+7LO_.4W$17)-/7(.-"KYP4GKVY6
MX,<@&L5S"V0Z%R30-9*-)4-O_)ZKVN<H7*&WMP'),;/G/,.(OG'9:+KV^Y8(
MK"^3YP76&/@F>ZVK?OWI^-E>J";99%I&LWJPNB$L<H<M8P=,YLPA$%-V '5/
M*00-_ D0#8TB#2A,IWI4S>*LR T?/3=*F0CQM=@[UT7PK-F (%9[ONE_?_UN
M+S9]0#L+BRJ-//\!*NV7[#<(5'Q0X,[6?J_M?_SR?C^6MO&TLE5QCD64W=RK
MO5[==ZK?]V.-:TZ2[6C?*F1RY D.U!N@.-F.IKKQ7!.:ULL]A3B6IZ0&0X5[
M$MI%["+E)]0@NF6Y,K?P;#//TN0E!!II\IHFK_T-S!K\ZMTFQ]^]NVS+S,?W
M+:Q;1N!$SO;]_:S%\DIR@,#7U*O6_9866.AGO*[[(#;Q%(KRC$R#YQ15*]ZZ
M9PW7<F_*#"^8=G'EAL&T\14.W,C.,XCA:$HA49+H]1S+K)\?+=+\6U/">F'&
M%I$]:)QQ:L^P5M.X>7_"D8*)948+.\"6(@#/73V[\:PWGE]9KHB"GR92,*1Q
M65JWPTL+9:J[.G?([GI,!GEM'\^:3RDUR[5?I&16]K$ [G1C884I9WH=&5?"
MPY*8F 7%Q0Y$\A?5/E=>PH.0>D)^2^.M%^4Z$^(:7F"??O!XNZSCA#G64BD(
MR,_+#L,"QB8W;2!@LZE7,J3W6=>#QWY>))=%U@Z(QJ9[SA$(XPG14\=8B!0V
MABB=0I<B<Y"# .03$Z^A=+$#F54B7.;[*%K8;I"-)2R(3H)M=+?\2%&XHR%M
M54V&M+_VCL#3H76TOYR \\F\;<Y0%)<E9:F\&I(1]VPL2155BJXG%F@N?(7R
M=BF7DS%V?$WG="X+D\B7'ZBH1*S;'%W(*92X='K$% 6A)<Y4D"$/=W1O5ZMI
M6J",",PU6B?(D^1RF:[L-V6^T37W->B+K,WO54US1IQK&A-&&T8O':+RP9-C
MA^ST**IC/K;N0T<O]$,6R#UCYAE;W]X9"H,&\(*XH3R<9CSG?L M*2DR,SX0
M"1"HC$=,F,K.[-1\X'?R"[#W<TGJONLV*QWPBS6?%554# VP26T3DQN!J +&
M!C=C$1]DP3TH);\+ML[";0C<D/%D"YY J.2./*MX><E)0LQ]XUT00T='=&&:
MA3*>)LPGB1R1O$2GQG+/RMG%ZRA1WZ14T% [!O2X3;I0#DM7&0H28-BQ]0%$
MA*I*DO(B$)/DP89Y+*6.P\LNLXH[%D O5$6&QO:.GNVZWEJ90?[/K,7(8 VK
MYBCZD.4Y&;/V"<&(H )[<%**VT7E(\^\#T&%*6G1'/4 T42#8QI)A%)ZGPM5
M-/1RLXXHDRT][]Z?Y,-H4<YNOJ&>9-<OS65/R_::7DNCIMP@Z]]R$IF*?UA@
M>2XL R.M6@.[TJ6V5LNP44KDFL*MYS J>,RBJ!+:;1YQYP=33 \/N3(8?W"4
M/#O\Z?#M8?(&7)<N>7P_31X_@O__%O[_NS1Y>,1H_^^P,750SX.G6Q;DA0CK
M9X=C2*@+P(^!Y0,V^*8M4#H$CYL!]<NQ.93#L24# 1C +J:'',GX'Q:5M?J[
M=E5=//P5:+//0!MGH=$=)XM\7<^('8F-F__M$-S3 \!K<I*0;WR-!J:60Q[]
M,(5OB.D-P<?A^=T%O2)!Y]!)N!R8JTEEAUS4;I8S-_P$F9@%/G]9]]B$C<Z9
M%B_T8EZM4HXPX,F^SH+?44>D:3Y]O&FI^M$.@]96MB$8Y%JSH=T$N+802^#'
MM/1!NL)GD)SH,,;#72P5'WE)^:?*#[]P! KP";A()8SWI8QK1;HYQT]';'U@
M+<Z)F+[:4/1*1X-F_=%=^5]E[K)^*NEX5)F!-"$;!Z;GI,V(4%/(V&-_YHS/
M:,3A\6C$X7"Q FX>SVQ"9DIN]Q,$3BE-".65?=9TJP)!;<=(1L!#X<,="5GC
M4\K%L]U4M)M]!06\+-ML(^[ '/=@)ZONRIC'""G[FZ+T\(QB/O;@T0/Z\[-#
M%X >/7QP/[OW9'XPG\W,]]^<7G8(P*O!/6 \W[L--K/5TF<\>:%3>Y5G)!L_
MD>0\8\FA;S\\&G[[X9,'3Y,"SG+Q^Z%< 500TFT,OH_PN&VOD>%KX :XKX\(
M8>UJ#U;9>AACYO/DZ+O!?;ODP7??TM<??/?$:_?Q'=S3F+9/#P:FQ1)9?.DH
MG]\0AP[SE."5CQ=4H=%?.6C6TV_WO2[Y\LWQ7D#1IR0G=Z)G*2LD,''[XKO%
MWA>+TQKG63)__@O%@Y ^T#A3OC=U7)X\!1<\E'BO'BN4V6DQUQ-"QPM1>#WF
M/YP.QJ]O^78V4\"]*N#D@-EO_ON_7KY\Z9)6#27*+$NA(^\YGSF5[;[[\K^W
M?1-N>:X<KQ3S8'KTG2-+YF5Z,-0+7?+=?;M*!^?PU%>'/+&S2T*8!HJ G#7B
MY!0PI 9KG@/;S3,PS8+V1N[O<N2#CU$&ZYPL@O@#-"UKF "SVJ)2(EH#:=P/
MCGHWS5 [VS[+1$/0C>76@6T^'2N5$/(<N.]I@^,^];,$%^NW3+5LPI%S;O*A
M&U@GO-RI3PR3-R*M3C$PV8!V#3;"^6BCSI6H7[9+.V_=?-(LO.NO,)4Q':XQ
MN2[.#U\PTX(((>@<D5A3GS2<_E%\<3.OY)FZH.,V;&Q#KJD3GE^K+AS1&DMD
M HO04?H4RR+F Z 9$<1 Z0+S:VW)!&,%OT2^Y*+O*XUA<NH<1AHM<AREL5?6
MR4&0W>78!^<6C*;[A*FKT85.IU;93BH-NQ)<N[A#3Q*!WTZ<TU/75-@E4P^<
MT'L[W@VR6H0)Y_F2.<>->3'/:'?HP)JB+TH8%TO)[=GBQI/LT! "E[S5+.]N
M\-RRLUC.#&^,^:?+T7&PQ\@WB^MF+VQM>T*[F)$ET_S2OFA.JR,$]&XJ)]W;
M.0%W-'I>K[=&SUMY=+)!61,S07./7]&*#O9C$_F!XSX0&IXE$KB4/0T":Q9G
MJ:4W6&!;8$M#EC@WPGM!)3DRT_1ST2[*+M,YZ,'5#(L"CHIHVRP8:RT#5K&-
M=@,"G%$>9O!U$_E.\BZX*2+8'$&D54/*!O>R:Y>[D3L$5[JC\O7[[U]L0-C'
MN%&=9,J"X=!8UM_4PJ&#KE_6<I5CS#A)M(OLW.HDJ&!J-544>#968*9L&H^T
M\X ?9C#QIK[D&:KH[)&?:UY[D!0<7"UE*$/%;#%4VCPMP=F@R6'3"YQJ@PCY
M.L&+\SAB>E6T$VIWS("$W2>67L,.6ER'F8&N"QRL;^JH>?&9:"^VOX'CUH&C
MNBC)9F;NJ.><]<))EC<\V?%NJHBVG6YJ::Q//Z2\(78MDF:'G^W;DI=["CHI
M[@]!$6A#BIKQCH&G@F<&/[C*SK2Z)<.%S?":42/3@/K9B3+S^@1&1*X/GC<_
MR@33.!N?R16@_Y<1A4R;F"DZ C%L>%'\[[R@ 0<('/'#5YA2#&^4G\M,CM$;
MC%%2^N"$;4*EX]"$;L"@&RH]?B<YN,/7^LQR_;4\&)0']^RX'Z.!=21UX&%R
MH=V-_16XS;B;%WM(SXLVPNQE"+L^F@<+W+2J8JHV'"5#8#ZI,4K[$,*RV(T<
MCJ%.98;L*B.B*QX.R"WJZ!"GP0/?327^Y'!*A=]<HGG[&('SHLX,[$&V\B;3
MXH=),*ITX1Z14I7HVQCJ2A9^5/I4%[N30G4P/55R/Z5J(E@YQ@H&^?TW+%['
M!"!U/NVH$,MZ=N.-.HW(1IWJ1UV8R&0X92Q&+C@BPE0E+BJ4Y=C7W@;87-.S
M@)H]0*1>$!"<9RY[(),.P>V0ZXX([6TBDQF<GSR8OB,GDB77A(0&KLH2SL33
M+$>YM"^"=*]K<CN7OI> 9OYJ/PW2RN!*JTRH<9B*PQH/@L=!59*#S9/G#2P%
M9U!=#,9QGM,1SPP\O<[_\N='3WZ@]&^G'F'!P\S."W4XS0-Z;D;'Q&R#SJN?
M:CCT<R0=@\<FK-E26"8("6/,K+Z'LJGYY6O:R*-.0V+"P)HNE^>E -4L!>7P
M\:T',7P5,VQD)")K]/%;&44/+QK;GM3+#6$PG3QY1DU>D31\^2Y\^^Y:K\\=
M567\;@YYWJQ+[L6-SI;&#B !_$7=KB!<FG*] DUPH-2?(-;-17&.W1V.*-(1
M2B^M#6RXE\TI I0<=N<X'M<!WP%"GO[CJAW4+N>FD#C:$\:_T"&)K9*F^^ 6
METIR'7J-G74;4<,0['P,_X^H8;\.0C9EUJ&IJTL>>6B7CM^94@@QB@U=O,'=
M@^5CAM;D  NV :!%Z3TB*] -1HP\E5S)C.5_SF/':;*OA-.85/9XB^#-(90M
M*WZ6J2,.GR>%$8RNB6EF/FZ?25M\'I6WJ2N:MPZ'97W)\0'(HE.$H'Z%I"X(
M<7 GJ+//G$LQS7@2.,0GFA;:9]Y#S9#R)33)9;)3#55B-$R!&W[BT>/KX1)^
M/7Q3(^3<X^M),(<.U@N_28CM^''S*WQC!W06[U:&5:K+[C04VT$[I;RF"KV<
M 9&&Z(E*-<'*?-W48J"'S;0NGY=9\N+YS\=O!Q.91D_)]2A*WUZA$:YY[MFW
MW>)]&3_8>J.4 #9 _JS-B)(95X4\U4</<"Q@O&_M<!H@?ZN#ONGYL/L9]+UV
MP!NSX^_Z9IW\2NB%/4HIT"D@IZWPY]0XG]Q@6/9:#NL<JJ@5.FU3E]&3G#H6
M_@X%FS]MJD'NUV-O7NO!N%@\UUDP"ZK-7(!"K?1RG\E(B?_L"_CZFV#>V*0;
MNJ3./G7R6RY]"S3"4N8EO@,07..^=#9,WUF"!,F**YW:TH582+3 6&BOL,I>
MHP6- ["YD?*:JQ56N:EL9.P_K$S32@&[I:F.@ST8+2WGWWD;Z=)F6IZ.)\R"
MO3BEHM:\$-:^NZIPIB>U[:?"><XY%+*=WE"Q++WS ?PSPDK<M/IY_E'9I.@!
M_?1L4LPSHR//;7/;L"[[D(A*(RX-CSIRG2=!1Y]BX"BG4+IT2G@?*EZ,:X8E
MY5H62EA+3AZ&4ZSJ?+@Q0+MM.+4(Z]6S*TG8G8RA\B0%-+>!$??>A8O/3YO)
M*ZU)TRD%*?7VEW0[T)8?I,+K$S>F[WP@+NR@#0* F+]F-\I!GX\>'B!4&_Z#
M,YJ/'L'_/S[(9V&M-B!$;]J)%X-S\7*IB58V"'PV:(%(F=/4S6Y(*Q$].,Q"
M4CN@?.#1HD=*:ES(!Q "@IPCL%&^(9[<<8>570J<HEF57-9FEIO!!WPB2*-
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M"FEEB*+KO2YY0J< %DW3Q)8X:@"J" ,!11BE$:=14)\[?5\_' 'L, *)MM=
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M>J)NW,_#\4)&SV+_U<T]X0TWS1VLFKS$M"'E^AQW:2JS+%"$ML<\X]''5S'
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M#&Y!S6OXW!',EPD>!QL0@WM&-V5B^5,!P=$#48YJW9O![GDIHV!"M 0^[+S
M_5IEN;*OC&\ 4IF=T/W=LTT.ZE80D (J@UJ$LD.?7[&L7JP1"PSWU2&"<.*)
M#Z$O=)@?^,5Z"UQP/R0G301,9#9\:J5E_P5HY*" A@]/IP_Q *?8SFQ5(#*A
M"#/B[L![Y]R?##,Y@#E!<+ L#8^2]>NE_<';<$4H/T1.*('CCC2KKS:8X,'R
M7_>>)8-6 27#:J&BIH>7DQBAQY,^33>):9 >=73G[([P=9CT4K@WYY3]G^"N
MHF(M'ZI4O4G\9[=9K3+9>N?M$-;;8Y4Y,4J$QEV"/AZ[4Y[W68A\G#0P03CI
M$WC/J_<DV%&CY6YV_;YBV/89PS:4;C1DJPTG!AFTL%IM:BKH.E3O4&MYM6P'
MCM#0.S?G SSTQ8:'XC%04X14_^XUF?P]E7)QAUH!_HNB2N )$'@<-K+<U L9
M,\94Z&T#5Q,D<X8T-%Y++R2OZ=6Y$W>C$"6W8$^(4[OA40F98TV3&UFOL[JY
M($^"T\"D6CNK")Q=!\/;EPN<G8*/.9H$70;#!?B7Y<*'4LYHL@TO\L,[&E%\
MN&41Q0L<EH<;\W/;7/2GNN'[%E:X"6-UTVM"D9-N0@(E1;AD462^@@\1[L3[
M35< J7126,]'T*+.6]LA[/Z7&_AU><O$_FU1%Q>DP2?:2 YO\@0D+Y=I,,XY
MK%&?EBU:O)KHOK+6 ;I+Z;CQ5.8^FS/9+K/_7;NZ5_M#/"H(@^C1;PN,8,"I
MI-$E'$($@T%/LT[RPD7M\ 9%/LY0IN&VVV5(=6@3_"KI3C$UV]KM-;VA+5-V
MF_YSI-3=(&H3BQE;OQQQ'SRB6;R.RUCI98L"5$9!3I!+TUC(\&_20GC7G0;%
M?.33,'-/QDVHUV#K@5_0NLHHZ^CJ28Y[Y^5.KZCI$U9MVPV5]V=1H8=EU( V
M.G]W'P?%6])6*U214B!W'L$_9+*P23Q([L;G:G!_0M?6IFY,7Z>K]4V>(9M%
M'T( 2IV0O2:G>&(IQN?N,/D)<]S$F.!>?Z I>T83I'Y: P,,?+9-%&5<ERH
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M[JB.7=XR'3L<.+I7([:'CA I0$?123(J#YILG;WJNEE=8PEC1(,WGYI)/#%
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MU["V%VXO$?3M^TYQ]J)/5!N%&."AX:Z,S;QLL,FV!+4ES")U$"D6=HM!FSP
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MP3'TW]89OUI]UDH21MF()+DY6+G9A(A_BFH\BP6LG00M2.<"@YZVDJ)..F%
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MF>';1E5FAO92%B0GA:+"R!JU72W@4@<-=[M('7DE6;,H@\**HE4 A56O$E7
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M-?G705(%I<3MI1Q+<\6ZWXB$G."(RQZFE$DP0>+BBPYK*\[@^R_1)SPWW=&
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MHRJ_ECE@%,0=,2&G=3)EA%T"X0SUIS@(1H6&;Y!U<T2GS<E27Q5!S"I58E"
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MV]'VD_S5&S,6=R#<ZP.F#[Y]8>T>BJ5/]QHA^T*CO?\#4$L! A0#%     @
M%D1Z4BXGD2<L&0  %)T  !$              ( !     &5O;',M,C R,3 S
M,C8N:'1M4$L! A0#%     @ %D1Z4B-JE)V) @  ?@D  !$
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M4$L! A0#%     @ %D1Z4F8)K^'=!@  BS,  !4              ( ![2H
M &5O;',M,C R,3 S,C9?<')E+GAM;%!+ 0(4 Q0    ( !9$>E)]ZR##$ZH
M (!7!  .              "  ?TQ  !E>#$Q,#,R-C(Q+FAT;5!+ 0(4 Q0
M   ( !9$>E+-4.7A+0H  "M)   -              "  3S<  !E>#4Q,S(V
<,C$N:'1M4$L%!@     (  @  0(  )3F      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
